Vocal cord dysfunction

VOCALCORDDYS

human african trypanosomiasis: A parasitic disorder caused by protozoa of the Trypanosoma brucei species. It is transmitted by flies and is endemic in various regions of Sub-Saharan Africa. Signs and symptoms include fever, joint pain, headache, and significant swelling of the lymph nodes. If left untreated, the parasitic infection causes anemia, heart, kidney, and endocrine failure, and neurologic damage. Subsequently patients develop confusion, disruption of the sleep cycle, and mental deterioration. The infection may lead to coma and death.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J38 Cause of death: ICD-10 — J38 2 out of 7 registries used, show all original rules.	7578
4. Check minimum number of events None	7578
5. Include endpoints None	7578
6. Filter based on genotype QC (FinnGen only)	7322

Control definitions (FinnGen only)

Control exclude: ASTHMA_COMORB

Extra metadata

First used in FinnGen datafreeze: DF9
Parent code in ICD-10: J38

NAME	VOCALCORDDYS
CONTROL_EXCLUDE	ASTHMA_COMORB
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J38
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J38
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Vocal cord dysfunction based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	42520	24121	18181
Only index persons	38879	22738	16141
Unadjusted period prevalence (%)
Whole population	0.61	0.69	0.51
Only index persons	0.74	0.84	0.62
Median age at first event (years)
Whole population	52.45	51.19	53.98
Only index persons	51.86	50.83	53.31

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7322	4543	2779
Unadjusted period prevalence (%)	1.48	1.61	1.27
Median age at first event (years)	55.27	52.04	60.56

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7493: Matched controls
67214

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.1

322.7

1665

5603

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

5.4

321.9

699

1252

N05AH04

ATC

quetiapine; oral

4.1

320.7

1031

2545

E66.01

ICD-10 Finland

Obesity due to excess calories

8.2

318.9

457

527

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.7

318.7

828

1732

XF400

NOMESCO Finland

ECG with 12 standard connections

4.1

317.6

1019

2511

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

10.2

317.3

385

356

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

17.2

315.8

281

152

104

Kela drug reimbursment

Thyroid insufficiency

4.7

313.5

815

1705

Z01.8

ICD-10 Finland

Other specified special examinations

3.3

307.7

1897

6340

Z96.1

ICD-10 Finland

Presence of intraocular lens

12.5

307.7

646

505

J38.7

ICD-10 Finland

Other diseases of larynx

322.5

307.7

774

H03AA01

ATC

levothyroxine sodium; systemic

2.9

307.7

2058

7672

J37.0

ICD-10 Finland

Chronic laryngitis

26.4

307.7

1235

498

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

18.6

307.7

305

153

A10BK03

ATC

empagliflozin; oral

254.6

307.7

403

R49.08

ICD-10 Finland

Other specified dysphonia

24.3

307.7

823

339

A10BK01

ATC

dapagliflozin; oral

93.2

307.7

309

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

121.9

307.7

237

D14.1

ICD-10 Finland

Benign neoplasm: Larynx

35.7

307.7

320

J38.4

ICD-10 Finland

Oedema of larynx

765.5

307.7

698

UDQ02

NOMESCO Finland

Direct laryngoscopy

36.6

307.7

313

F32.9

ICD-10 Finland

Depressive episode, unspecified

7.1

307.7

738

1019

UGC12

NOMESCO Finland

Flexible bronchoscopy

6.6

307.7

897

1347

TFP20

NOMESCO Finland

Cardiodefibrillation

230.3

307.7

296

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

79.6

307.7

224

UDQ22

NOMESCO Finland

Microlaryngoscopy

103.7

307.7

547

UDH02

NOMESCO Finland

Rhinopharyngoscopy

5.9

307.7

869

1463

A02BC03

ATC

lansoprazole; oral

2.9

307.7

2239

8546

A10AE04

ATC

insulin glargine; parenteral

156.5

307.7

381

R13

ICD-10 Finland

Dysphagia

7.8

307.7

884

1132

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

5.3

307.7

1106

2117

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

55.3

307.7

239

A10BH01

ATC

sitagliptin; oral

996.7

307.7

420

N02AX02

ATC

tramadol; systemic, rectal

2.7

307.7

3230

14916

R4130

NOMESCO Finland

Speech therapy

20.2

307.7

606

291

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

307.7

673

K78

ICPC

Atrial fibrillation/flutter

18.3

307.7

292

149

Z50.5

ICD-10 Finland

Speech therapy

28.6

307.7

439

146

G47.3

ICD-10 Finland

Sleep apnoea

3.5

307.7

1582

4806

N03AX16

ATC

[U] pregabalin

3.3

307.7

1850

5992

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

79.6

307.7

435

103

Kela drug reimbursment

Diabetes, insulin-treated

866.9

307.7

1282

R07.4

ICD-10 Finland

Chest pain, unspecified

3.5

307.7

1945

6116

BAA60

NOMESCO Finland

Total thyroidectomy

10.2

307.7

595

564

I48

ICD-10 Finland

Atrial fibrillation and flutter

96.7

307.7

1025

110

H25.1

ICD-10 Finland

Senile nuclear cataract

22.7

307.7

1247

586

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.8

307.7

2385

9703

SPAT1262

SPAT

Handing over of treatment supplies

6.8

307.7

918

1344

UDQ12

NOMESCO Finland

Flexible laryngoscopy

28.8

307.7

2188

948

DQA10

NOMESCO Finland

Biopsy of larynx

88.1

307.7

329

R49.09

ICD-10 Finland

Unspecified dysphonia

18.0

307.7

286

148

J38.5

ICD-10 Finland

Laryngeal spasm

424.4

307.7

362

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

105.0

307.7

472

J38.2

ICD-10 Finland

Nodules of vocal cords

1026.7

307.7

817

WX100

NOMESCO Finland

Conjunctival surface anesthesia

21.4

307.7

628

286

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

13.0

307.7

982

773

A10AB05

ATC

insulin aspart; parenteral

54.1

307.7

318

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

5.4

307.7

1028

1906

R49.01

ICD-10 Finland

Functional dysphonia

15.4

307.7

867

565

WX408

NOMESCO Finland

General anesthesy, balanced

3.1

307.7

2344

8507

AN1

Coronary angiography

152.9

307.7

464

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.6

307.7

3687

11769

A02BC01

ATC

omeprazole; systemic

2.9

307.7

2102

7938

215

Kela drug reimbursment

Diabetes, non-insulin-treated

6327.7

307.7

1209

R03AC02

ATC

salbutamol; inhalant

2.9

307.7

4541

23199

C01AA05

ATC

digoxin; systemic

19.3

307.7

318

154

I25.1

ICD-10 Finland

Atherosclerotic heart disease

117.0

307.7

1103

I20.99

ICD-10 Finland

Angina pectoris, unspecified

78.1

307.7

293

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

45.6

307.7

1610

401

J38.1

ICD-10 Finland

Polyp of vocal cord and larynx

13597.4

307.7

1272

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

8.3

307.7

1301

1666

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

672.5

307.7

743

R23

ICPC

Voice symptom/complaint

9.9

307.7

463

443

C07AB07

ATC

bisoprolol; oral

4.3

307.7

3135

9561

H25.8

ICD-10 Finland

Other senile cataract

42.1

307.7

517

118

T90

ICPC

Diabetes non-insulin dependent

19.3

307.7

1219

669

A02BC05

ATC

esomeprazole; systemic

3.6

307.7

3754

14639

AA1AD

NOMESCO Finland

CT of head and brain

3.9

307.7

1835

5101

C01DA14

ATC

isosorbide mononitrate; oral

25.7

307.7

745

288

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

103.6

307.7

425

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

16.3

307.7

838

515

B01AC04

ATC

clopidogrel; oral

12.5

307.7

851

683

207

Kela drug reimbursment

Chronic arrhythmias

125.6

307.7

722

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

10.3

307.7

469

433

E11

ICD-10 Finland

Type 2 diabetes mellitus

20.7

307.7

709

338

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

69.4

307.7

354

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

3.8

307.7

1402

3847

R33

ICD-10 Finland

Retention of urine

25.1

307.7

360

135

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

16384.0

307.7

2978

J45.9

ICD-10 Finland

Asthma, unspecified

4.0

307.7

1696

4545

DQE10

NOMESCO Finland

Injection of foreign material into vocal cord

631.6

307.7

337

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

5.1

307.7

1441

2974

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

49.1

307.7

777

158

A10BA02

ATC

metformin; oral

34.5

307.7

1384

439

H02AB06

ATC

prednisolone; systemic

3.5

307.7

3997

16487

R06.5

ICD-10 Finland

Mouth breathing

9.3

307.7

587

608

R02

ICPC

Shortness of breath/dyspnoea

4.4

307.7

1004

2306

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

20.8

307.7

310

139

I50.0

ICD-10 Finland

Congestive heart failure

21.5

307.7

282

122

A10AC01

ATC

insulin (human); parenteral

19.7

307.7

288

136

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

40.8

307.7

255

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

+∞

307.7

1247

A02BC02

ATC

pantoprazole; systemic

3.5

307.7

5364

28266

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

41.9

307.7

1149

289

B01AA03

ATC

warfarin; systemic

7.1

307.7

935

1323

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

6.2

307.7

876

1403

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

6.2

307.7

1203

2000

H26.4

ICD-10 Finland

After-cataract

54.3

307.7

466

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

18.1

307.7

354

184

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

189.1

307.7

1114

Angiography of the heart and coronary arteries

48.3

307.7

245

J38.3

ICD-10 Finland

Other diseases of vocal cords

1345.0

307.7

1640

I20.09

ICD-10 Finland

Unstable angina

157.5

307.7

238

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

115.3

307.7

320

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

5.4

307.7

2469

5596

B01AF02

ATC

apixaban; oral

8.0

307.7

590

711

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

14.6

307.7

358

230

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

12.2

307.7

364

280

CJB10

NOMESCO Finland

Laser discission of secondary cataract

93.1

307.7

375

I50.9

ICD-10 Finland

Heart failure, unspecified

17.3

307.7

650

366

C03CA01

ATC

furosemide; systemic

5.7

307.7

1755

3444

R49.0

ICD-10 Finland

Dysphonia

11.9

307.7

512

411

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

106.2

307.7

393

EP1AE

NOMESCO Finland

Neck ultrasound examination

6.9

307.7

882

1275

R06.0

ICD-10 Finland

Dyspnoea

4.9

307.7

2341

5669

R03BB04

ATC

tiotropium bromide; inhalant

6.6

307.7

966

1476

A10BB12

ATC

glimepiride; oral

202.3

307.7

219

Z3226

NOMESCO Finland

Physiotherapist

3.2

306.5

1467

4708

C10AA05

ATC

atorvastatin; oral

2.7

302.7

2398

10122

R03AK06

ATC

salmeterol and fluticasone; inhalant

3.5

299.2

1202

3453

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.0

297.0

1654

5789

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2685.8

296.5

297

E66.8

ICD-10 Finland

Other obesity

17.6

295.7

260

137

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

23.9

294.9

228

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

18.8

294.0

251

124

C10AA01

ATC

simvastatin; oral

2.6

292.8

2290

9579

I25

ICD-10 Finland

Chronic ischaemic heart disease

49.7

290.9

184

ZXA10

NOMESCO Finland

Bilateral

3.3

289.7

1313

4066

C03DA01

ATC

spironolactone; oral

5.2

288.9

659

1231

N06AX11

ATC

mirtazapine; oral

2.6

287.6

2279

9582

N06AX16

ATC

venlafaxine; oral

4.0

287.3

932

2308

ZXE00

NOMESCO Finland

One hour or less

2.5

284.0

2955

14110

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

13.5

283.4

286

197

N06AB04

ATC

citalopram; systemic

3.2

280.8

1341

4281

N05BA04

ATC

oxazepam; oral

2.9

279.7

1734

6417

I10

ICD-10 Finland

Essential (primary) hypertension

2.4

276.4

3634

19182

N05CF01

ATC

zopiclone; oral

2.6

272.9

2189

9222

RL210, ,

NOMESCO Finland

38.9

272.6

182

N06AX21

ATC

duloxetine; oral

4.2

272.4

824

1935

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

7.0

269.7

442

595

XF402

NOMESCO Finland

ECG with work load test

5.0

268.9

635

1221

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

5.1

268.2

614

1149

N03AX12

ATC

[U] gabapentin; oral

3.3

266.7

1188

3628

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.0

264.7

1446

4978

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.8

262.9

658

1329

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

15.1

262.5

249

153

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

+∞

260.4

259

TPH04

NOMESCO Finland

Cathetrisation of vein

2.9

258.2

1504

5359

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

256.4

255

UJF32

NOMESCO Finland

Coloscopy

2.7

254.1

1707

6553

C09AA05

ATC

ramipril; oral

3.1

253.7

1238

3987

P01BA02

ATC

hydroxychloroquine; oral

6.1

253.0

474

734

D38.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Larynx

29.0

252.7

183

WX892

NOMESCO Finland

Monitored bed care

5.8

252.7

505

833

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

5.5

251.5

529

916

ZXC10

NOMESCO Finland

Use of laser

8.1

250.0

359

414

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

17.3

249.0

220

117

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

11.9

248.1

269

209

R03DC03

ATC

montelukast; oral

2.8

247.3

1487

5379

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

30.1

247.3

177

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

247.2

2720

13138

T36

ICD-10 Finland

Poisoning by systemic antibiotics

16.3

245.2

223

126

C08CA01

ATC

amlodipine; oral

2.5

244.9

2215

9798

C10AX09

ATC

ezetimibe; oral

3.9

244.6

811

2031

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

86.5

244.5

142

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

9.3

241.0

310

ZXE10

NOMESCO Finland

More than one and less than three hours

2.3

239.7

2621

12590

H02AB04

ATC

methylprednisolone; systemic

3.1

237.6

1194

3902

C07AB02

ATC

metoprolol; systemic

3.3

237.5

1047

3164

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

37.3

235.8

159

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

94.8

234.9

135

R03BA08

ATC

ciclesonide; inhalant

3.6

232.8

861

2323

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

108.7

231.1

131

H02AB07

ATC

prednisone; oral

3.2

230.3

1044

3206

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

229.1

228

I25.2

ICD-10 Finland

Old myocardial infarction

542.5

228.2

235

R03AK08

ATC

formoterol and beclometasone; inhalant

5.6

228.0

472

804

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

5.4

227.2

488

860

XF404

NOMESCO Finland

Ambulatory ECG

5.3

227.1

499

898

J01MA12

ATC

levofloxacin; systemic

2.9

226.5

1329

4726

N02BE01

ATC

paracetamol; systemic, rectal

3.0

225.7

6531

46673

J04.0

ICD-10 Finland

Acute laryngitis

5.2

223.8

502

920

J45.1

ICD-10 Finland

Nonallergic asthma

4.4

222.0

618

1356

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

6.5

221.0

389

564

I47.1

ICD-10 Finland

Supraventricular tachycardia

18.2

220.0

190

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

4.4

220.0

602

1303

I50.1

ICD-10 Finland

Left ventricular failure

25.6

219.0

165

ZXD10

NOMESCO Finland

Scheduled procedure

2.2

218.2

2826

14445

L28

ICPC

Limited function/disability (L)

3.1

217.2

1055

3370

WX872

NOMESCO Finland

Intensive care

9.3

217.1

278

276

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

5.1

215.9

494

921

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

8.0

215.2

313

366

R49.03

ICD-10 Finland

Atrophic dysphonia

13.9

214.8

212

140

A28

ICPC

Limited function/disability NOS

3.4

214.1

880

2538

R42

ICD-10 Finland

Dizziness and giddiness

2.6

213.6

1511

5902

R03BA05

ATC

fluticasone; inhalant

2.6

213.1

1508

5891

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

657.4

208.8

214

T89

ICPC

Diabetes insulin dependent

63.8

208.1

126

A02BA02

ATC

ranitidine; systemic

2.7

207.2

1315

4856

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.4

207.1

854

2466

A02BC04

ATC

rabeprazole; oral

3.5

205.3

794

2200

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

4.7

204.3

508

1016

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

36.0

202.8

138

R53

ICD-10 Finland

Malaise and fatigue

2.5

202.0

1575

6430

L04AX01

ATC

azathioprine; systemic

11.6

201.3

222

177

R5140

NOMESCO Finland

Monitoring the use of the aid

3.6

200.6

729

1937

J01DB01

ATC

cefalexin; oral

2.5

199.9

6099

42958

ZXD05

NOMESCO Finland

Urgent procedure

2.3

198.9

2016

9249

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.1

198.5

3171

17423

J01FA06

ATC

roxithromycin; oral

2.1

198.1

2966

15900

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.3

197.7

562

1251

N05AH03

ATC

olanzapine; systemic

8.8

197.2

264

278

201

Kela drug reimbursment

Chronic cardiac insufficiency

14.5

197.2

190

120

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

19.9

196.5

163

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.4

196.4

788

2233

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

9.0

196.4

258

265

N06AB10

ATC

escitalopram; oral

2.7

196.2

1305

4925

A10BJ06

ATC

semaglutide; parenteral

+∞

195.7

195

GD1AD

NOMESCO Finland

Thorax CT examination

4.9

195.4

467

903

WX002

NOMESCO Finland

Sedation and analgesia

2.7

193.8

1279

4806

R51.80

ICD-10 Finland

Headache

2.8

192.7

1137

4031

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

+∞

192.7

192

J01FF01

ATC

clindamycin; systemic

2.3

191.6

1937

8857

XG474

NOMESCO Finland

Exhalation nntrogen oxide

6.8

190.9

320

440

J01AA02

ATC

doxycycline; systemic

2.3

190.5

5766

39952

Z3231

NOMESCO Finland

Registered nurse

2.4

190.4

1752

7689

S18

ICPC

Laceration/cut

2.1

190.0

3109

17161

A07EC02

ATC

mesalazine; oral, rectal

10.1

190.0

230

211

N02AJ06

ATC

codeine and paracetamol; systemic

2.1

189.3

2953

16009

A06AC01

ATC

ispaghula (psylla seeds); oral

2.4

189.1

1747

7679

N06AA09

ATC

amitriptyline; systemic

3.8

187.9

631

1586

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.4

187.8

1635

6998

F29

ICD-10 Finland

Unspecified nonorganic psychosis

58.2

187.0

115

XG410

NOMESCO Finland

Flow-volume spirometry

6.0

186.4

355

557

A10AE05

ATC

insulin detemir; parenteral

355.1

185.6

194

XCK10

NOMESCO Finland

Photography of fundus of eye

4.9

185.5

444

859

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

+∞

184.6

184

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.4

184.5

746

2122

A10BJ02

ATC

liraglutide; parenteral

38.7

184.0

123

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.1

183.4

2932

15993

N05BA01

ATC

diazepam; systemic, rectal

3.2

182.2

802

2404

205

Kela drug reimbursment

Chronic hypertension

2.6

181.0

1256

4826

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

2.2

180.8

1975

9294

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.0

179.7

3933

23937

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.3

179.0

1846

8479

SPAT1263

SPAT

Sampling

2.1

177.6

2741

14718

M79.6

ICD-10 Finland

Pain in limb

2.0

177.1

2905

15943

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

9.7

177.1

219

207

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

11.3

175.7

196

159

A10AB04

ATC

insulin lispro; parenteral

55.1

175.6

109

L04AX03

ATC

methotrexate; systemic

4.1

175.6

528

1224

UJF30

NOMESCO Finland

Ileoscopy through colon

3.4

175.0

686

1911

R04.2

ICD-10 Finland

Haemoptysis

7.0

174.9

283

374

A06AD11

ATC

lactulose; oral

3.0

174.8

873

2816

R03BA02

ATC

budesonide; inhalant

2.5

174.3

1396

5734

A10BH05

ATC

linagliptin; oral

414.0

174.1

181

E66.00

ICD-10 Finland

Metabolic syndrome

8.2

172.9

245

277

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

13.4

172.1

173

118

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

26.5

172.0

128

XG466

NOMESCO Finland

Sleep oxymetry

9.8

171.6

212

200

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1659.8

171.4

173

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

5.2

170.5

379

687

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

+∞

169.5

169

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

9.6

169.0

211

202

R96

ICPC

Asthma

3.3

168.9

713

2080

R05

ICD-10 Finland

Cough

2.3

168.1

1638

7322

GBB00

NOMESCO Finland

Tracheostomy

14.4

167.4

162

103

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

7.1

167.3

269

353

TPH07

NOMESCO Finland

Cathetrisation of artery

3.4

167.0

683

1953

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

24.3

166.9

128

ZXA05

NOMESCO Finland

Left side

2.3

166.8

1604

7128

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

+∞

166.5

166

E66.9

ICD-10 Finland

Obesity, unspecified

14.5

166.0

160

101

N02AA05

ATC

oxycodone; systemic

2.6

165.9

1152

4415

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

5.5

165.7

342

579

UKC02

NOMESCO Finland

Cystoscopy

2.8

165.5

966

3390

N06AB03

ATC

fluoxetine; oral

3.2

165.1

722

2151

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.2

164.4

716

2128

UJC01

NOMESCO Finland

Scopy of lower throat

11.9

164.1

177

136

N05AX12

ATC

aripiprazole; systemic

15.9

163.5

150

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

7.2

162.6

256

328

J45

ICD-10 Finland

Asthma

3.0

162.5

835

2732

Z2446

NOMESCO Finland

Social worker

4.6

162.3

412

836

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

14.2

161.2

157

101

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

4.1

161.1

474

1080

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

3.7

160.5

551

1403

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

7.9

159.7

233

273

M54.5

ICD-10 Finland

Low back pain

2.0

159.3

2466

13144

I50

ICD-10 Finland

Heart failure

29.1

159.2

115

A07EA06

ATC

budesonide; oral, local oral

10.4

157.8

186

164

J01MA02

ATC

ciprofloxacin; systemic

2.0

157.7

2563

13888

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

3.0

157.3

769

2445

N03AX09

ATC

lamotrigine; oral

6.5

157.0

271

384

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.1

153.8

1857

9009

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.9

153.5

2885

16398

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

27.6

152.4

112

N05CD07

ATC

temazepam; oral

3.3

152.1

638

1850

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.6

151.7

1001

3731

OAB50, ,

SPAT

6.9

151.1

246

327

SPAT1254

SPAT

Administration of medicine

2.9

150.9

821

2768

A10AB01

ATC

insulin (human); parenteral

50.8

150.7

L01BA01

ATC

methotrexate; systemic

9.3

150.7

192

189

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.8

150.1

853

2944

SPAT1301

SPAT

No procedures

2.1

149.9

1916

9486

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

+∞

149.4

149

C01BC04

ATC

flecainide; systemic

16.4

149.4

135

R01AD09

ATC

mometasone; nasal

1.9

149.2

3442

20869

RP210, ,

NOMESCO Finland

47.9

149.0

R03AC13

ATC

formoterol; inhalant

4.2

148.6

425

947

R4110

NOMESCO Finland

Physiotherapy

2.1

148.5

1838

8986

A07AA02

ATC

nystatin; oral

3.9

148.1

464

1106

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.8

148.0

839

2891

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.1

147.4

1796

8725

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

+∞

147.4

147

SPAT1310

SPAT

Counselling related to known health issue

2.1

147.1

1986

10024

N06AB06

ATC

sertraline; oral

3.3

146.9

616

1785

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.4

146.7

1206

4980

L17

ICPC

Foot/toe symptom/complaint

2.1

146.5

1836

9011

B01AB05

ATC

enoxaparin; parenteral

2.0

146.4

2016

10247

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1382.2

146.3

148

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.0

146.0

2031

10360

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.4

146.0

589

1666

K90

ICPC

Stroke/cerebrovascular accident

21.1

145.8

118

R03BA01

ATC

beclometasone; inhalant

2.5

145.6

1047

4064

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.6

145.3

373

763

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.5

145.1

1026

3950

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

7.8

144.5

212

250

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.2

143.8

641

1927

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

24.4

143.7

110

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

6.4

143.3

250

358

N03AE01

ATC

clonazepam; systemic

4.5

143.3

376

783

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

7.5

143.0

218

269

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

+∞

142.3

142

WX734

NOMESCO Finland

JET-ventilation

176.3

141.8

154

ZXE20

NOMESCO Finland

More than three and less than five hours

2.7

141.5

854

3037

M48.0

ICD-10 Finland

Spinal stenosis

2.9

140.6

729

2390

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

4.0

140.5

425

987

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

36.0

139.6

N05AA02

ATC

levomepromazine; systemic

9.8

139.2

171

160

J46

ICD-10 Finland

Status asthmaticus

6.7

138.1

232

319

TFP34

NOMESCO Finland

Electrophysiological investigation

18.5

138.1

118

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

4.1

138.1

404

915

J01DA01

ATC

[U] cefalexin

1.8

137.6

4376

29057

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

4.3

136.8

380

827

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

5.0

136.5

309

568

ZXA00

NOMESCO Finland

Right side

2.1

136.2

1624

7794

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

6.8

136.2

225

304

ZY010

NOMESCO Finland

Hospital outpatient

5.7

135.9

268

434

A04

ICPC

Weakness/tiredness general

2.6

135.8

880

3241

I48.2

ICD-10 Finland

Chronic atrial fibrillation

427.9

135.8

141

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

633.9

135.4

139

G44.2

ICD-10 Finland

Tension-type headache

2.5

135.2

981

3816

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.8

134.7

769

2654

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

629.3

134.4

138

R03AK07

ATC

formoterol and budesonide; inhalant

2.1

134.1

1593

7629

S97

ICPC

Chronic ulcer skin

5.1

134.0

300

546

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.9

134.0

686

2231

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.6

133.7

872

3221

D64.9

ICD-10 Finland

Anaemia, unspecified

3.4

132.9

527

1472

SPAT1153

SPAT

Removal of sutures

2.0

132.9

2040

10716

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.5

132.6

935

3586

A11CC03

ATC

alfacalcidol; systemic

8.8

132.0

176

184

SPAT1097

SPAT

Recording of ECG

2.7

131.8

804

2870

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.6

131.8

910

3455

H26.02

ICD-10 Finland

Presenil cataract

21.7

131.3

105

Z2221

NOMESCO Finland

Medical doctor

2.0

131.3

1839

9350

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

5.6

131.1

263

433

WZC30

NOMESCO Finland

Teaching

2.4

130.5

1080

4456

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

34.0

130.3

R03AC03

ATC

terbutaline; inhalant

2.4

130.1

1034

4190

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.2

130.0

559

1642

8070/3-C32.0

ICD-O-3

Squamous cell carcinoma, NOS, of glottis

47.0

129.7

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

14.4

129.5

125

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.1

128.9

384

881

I20.90

ICD-10 Finland

Angina pectoris, unspecified

406.1

128.8

134

M04AA01

ATC

allopurinol; systemic

3.2

128.6

574

1724

R60.0

ICD-10 Finland

Localized oedema

2.8

128.4

710

2407

B01AC24

ATC

ticagrelor; oral

1188.9

128.2

130

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.8

128.2

711

2414

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

128.0

1138

4841

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

5.3

127.4

274

481

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.3

127.2

1206

5271

SPAT1229

SPAT

Assessment of need for aid

3.8

127.1

411

1001

K77

ICPC

Heart failure

32.3

127.0

WZC00

NOMESCO Finland

Treatment plan or consultation

1.9

127.0

2538

14502

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.8

126.8

696

2349

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

15.0

126.8

120

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

6.0

125.7

234

358

R07.0

ICD-10 Finland

Pain in throat

3.0

125.4

630

2025

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

17.3

124.7

110

M01AE03

ATC

ketoprofen; systemic, rectal

1.9

124.5

2494

14243

F10.09

ICD-10 Finland

Alcohol intoxication UNS

45.3

124.0

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

123.9

4998

35138

N06AX12

ATC

bupropion; oral

4.1

123.2

357

802

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.1

122.9

569

1745

M25.5

ICD-10 Finland

Pain in joint

1.9

122.9

2215

12222

A10BD07

ATC

metformin and sitagliptin; systemic

387.4

122.8

128

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.7

122.8

415

1042

WX402

NOMESCO Finland

General anaesthesia

2.1

122.7

1542

7515

L03

ICPC

Low back symptom/complaint

2.0

122.6

1808

9328

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

3.6

122.5

431

1112

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

3.2

122.3

530

1563

R01AD08

ATC

fluticasone; nasal

1.9

121.9

2145

11738

K76

ICPC

Ischaemic heart dis without angina

47.1

121.9

A11

ICPC

Chest pain NOS

3.4

121.6

479

1331

SPAT1216

SPAT

Assessment of functional ability

2.6

121.2

814

3043

A10AE06

ATC

insulin degludec; parenteral

1120.9

121.2

123

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.9

121.1

282

531

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

4.1

120.6

357

815

R03AC12

ATC

salmeterol; inhalant

4.3

120.5

336

733

J01FA10

ATC

azithromycin; systemic

1.8

120.2

4306

29102

R06AE07

ATC

cetirizine; oral

1.8

119.9

3171

19635

J45.8

ICD-10 Finland

Mixed asthma

5.2

119.5

260

461

B01AC06

ATC

acetylsalicylic acid; oral

31.7

119.3

A07EC01

ATC

sulfasalazine; oral, rectal

3.9

118.3

377

908

C07AA05

ATC

propranolol; systemic

2.1

118.1

1341

6281

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

16.6

118.1

106

G04CA02

ATC

tamsulosin; oral

2.2

118.0

1223

5529

R03AK11

ATC

formoterol and fluticasone; inhalant

5.3

117.6

250

434

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

3.5

117.6

446

1209

M79.0

ICD-10 Finland

Rheumatism, unspecified

6.1

117.6

214

320

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

117.2

1953

10475

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

8.5

116.9

160

173

J01CA04

ATC

amoxicillin; systemic

2.0

116.9

5911

44145

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

41.0

116.8

R50.9

ICD-10 Finland

Fever, unspecified

2.4

116.0

963

3966

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

115.8

1760

9148

I49.5

ICD-10 Finland

Sick sinus syndrome

10.0

115.8

140

128

UJD02

NOMESCO Finland

Gastroscopy

4.3

115.6

314

671

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.8

114.3

613

2040

N05AB03

ATC

perphenazine; systemic, rectal

10.0

114.2

138

126

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

114.2

3558

22984

P76

ICPC

Depressive disorder

4.2

113.8

321

706

R05FB02

ATC

cough suppressants and expectorants; systemic

1.8

113.5

2495

14568

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

57.6

113.5

XQ800

NOMESCO Finland

Prick test

2.8

113.5

621

2089

N06AX26

ATC

vortioxetine; oral

3.8

113.2

376

932

UJC12

NOMESCO Finland

Flexible oesophagoscopy

13.5

113.1

113

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.0

112.7

547

1722

J02AC01

ATC

fluconazole; systemic

1.8

112.7

2959

18192

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

26.3

112.5

I48.1

ICD-10 Finland

Persistent atrial fibrillation

160.2

112.5

123

R07.3

ICD-10 Finland

Other chest pain

2.8

112.4

609

2037

WX722

NOMESCO Finland

PEEP

4.9

112.1

264

502

M54.4

ICD-10 Finland

Lumbago with sciatica

2.2

112.0

1187

5404

R55

ICD-10 Finland

Syncope and collapse

2.8

111.9

608

2037

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

111.6

1241

5756

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

11.0

111.6

126

104

J20

ICD-10 Finland

Acute bronchitis

2.6

111.4

724

2659

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.5

110.9

411

1097

SPAT1249

SPAT

Treatment-related counselling outside office

1.8

110.6

2409

14005

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.2

110.3

1063

4657

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

3.2

109.7

475

1398

J01MA14

ATC

moxifloxacin; systemic

2.8

109.5

625

2149

N05AF03

ATC

chlorprothixene; systemic

17.4

109.4

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

12.5

109.1

114

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.6

109.1

708

2598

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.8

108.6

584

1945

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

4.9

108.5

255

484

SPAT1058

SPAT

PEF monitoring instruction

3.0

108.3

514

1597

N02BF02

ATC

pregabalin; oral

3.7

108.3

373

948

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

5.7

108.2

212

341

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

10.6

108.1

125

107

K59.09

ICD-10 Finland

Constipation, unspecified

3.5

107.6

403

1083

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

5.9

107.5

204

318

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

7.5

107.4

163

200

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

337.8

106.9

112

C10AA07

ATC

rosuvastatin; oral

1.9

106.9

1799

9637

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.4

106.7

858

3478

Z71.8

ICD-10 Finland

Other specified counselling

1.8

106.6

2004

11116

J01FA09

ATC

clarithromycin; systemic

1.8

106.3

2283

13185

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.3

106.2

428

1205

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

11.2

106.2

119

XF600

NOMESCO Finland

Bloodpressure measurement

3.7

106.2

364

922

F34.1

ICD-10 Finland

Dysthymia

7.2

106.0

166

211

C09AA02

ATC

enalapril; systemic

2.3

106.0

919

3848

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.1

105.8

1210

5662

P03

ICPC

Feeling depressed

3.0

105.2

515

1628

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

+∞

105.2

105

E0000UV, ,

ATC

1.7

104.9

2820

17356

I20.00

ICD-10 Finland

Unstable angina

331.6

104.9

110

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

5.8

104.3

200

315

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

24.2

104.1

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

11.5

103.8

114

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.7

103.7

625

2208

N17.9

ICD-10 Finland

Acute renal failure, unspecified

6.3

103.3

183

266

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.9

103.2

531

1725

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

13.6

102.6

102

PD5BD

NOMESCO Finland

Extensive CT of aorta

11.3

102.4

114

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

3.1

102.3

469

1427

P01AB01

ATC

metronidazole; oral, rectal

1.7

102.3

2736

16787

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.2

102.2

981

4282

AN4

Balloon angioplasty and drug eluding stent

+∞

102.1

102

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.3

102.0

890

3733

R03DA04

ATC

theophylline; systemic, rectal

3.7

102.0

343

857

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

7.8

101.8

149

175

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.2

101.8

447

1326

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

12.9

101.6

104

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.4

101.3

389

1062

UDC00

NOMESCO Finland

Ear microscopy

2.8

101.2

541

1794

XKD00

NOMESCO Finland

Uroflowmetry

2.3

101.2

845

3478

F61.0

ICD-10 Finland

Mixed personality disorders

27.9

101.1

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.5

100.9

261

536

C08DB01

ATC

diltiazem; oral

5.3

100.9

215

374

F41.1

ICD-10 Finland

Generalized anxiety disorder

4.7

100.7

246

482

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

100.7

1621

8537

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

8.2

100.6

141

157

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

14.1

100.6

JDB10

NOMESCO Finland

Percutaneous gastrostomy

7.0

100.4

162

213

R06.2

ICD-10 Finland

Wheezing

3.7

100.4

337

841

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.0

100.3

490

1546

I35.0

ICD-10 Finland

Aortic (valve) stenosis

5.5

100.3

204

340

C08CA13

ATC

lercanidipine; oral

2.5

100.1

708

2703

R04.0

ICD-10 Finland

Epistaxis

3.3

99.8

399

1117

M01AH01

ATC

celecoxib; oral

2.1

99.8

1167

5497

R95

ICPC

Chron obstructive pulmonary disease

6.2

99.7

178

261

JN3AD

NOMESCO Finland

Abdominal CT examination

2.5

99.4

672

2511

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.8

99.4

560

1910

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.4

99.2

391

1085

C01BD01

ATC

amiodarone; systemic

313.1

99.0

104

SPAT1260

SPAT

Consultation of another employee

2.1

99.0

1031

4646

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

13.7

98.9

A01

ICPC

Pain general/multiple sites

2.8

98.5

522

1723

PD5AD

NOMESCO Finland

CT of aorta

9.1

98.4

127

B01AC07

ATC

dipyridamole; systemic

7.4

98.3

150

185

R05

ICPC

Cough

1.9

98.0

1568

8231

R21

ICPC

Throat symptom/complaint

1.9

97.8

1540

8042

F10.25

ICD-10 Finland

Alcohol dependence continuous use

37.3

97.8

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

9.8

97.8

120

112

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.6

97.7

637

2338

SPAT1240

SPAT

Therapeutic discussion

2.7

97.7

566

1958

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

237.0

97.6

104

K84

ICPC

Heart disease other

10.7

97.4

112

C09CA01

ATC

losartan; oral

1.9

97.0

1401

7107

I42.0

ICD-10 Finland

Dilated cardiomyopathy

14.2

96.8

R01AD12

ATC

fluticasone furoate; nasal

1.7

96.4

2345

13957

A01AB09

ATC

miconazole; local oral

2.7

96.3

582

2057

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.4

95.6

739

2936

N05CF02

ATC

zolpidem; oral

2.1

95.2

1125

5313

SPAT1325

SPAT

Vaccination

1.8

95.1

1987

11313

R03BB01

ATC

ipratropium bromide; inhalant

4.3

95.0

256

543

F10.20

ICD-10 Finland

Alcohol dependence currently independent

25.1

94.9

R03AK03

ATC

[U] fenoterol and ipratropium bromide

3.6

94.9

329

839

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

4.5

94.8

244

499

M79.7

ICD-10 Finland

Fibromyalgia

4.8

94.8

226

434

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.5

94.5

665

2530

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

3.4

94.5

366

1004

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.8

94.4

517

1736

AN2

Balloon angioplasty, including several vessels

+∞

94.1

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.4

93.5

726

2890

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

183.6

93.4

101

C07AA07

ATC

sotalol; systemic

7.5

93.3

141

172

J31.0

ICD-10 Finland

Chronic rhinitis

2.5

93.3

624

2318

DQE20

NOMESCO Finland

Implantation of foreign material in vocal chord

+∞

93.1

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.4

92.8

709

2801

M05BA04

ATC

alendronic acid; oral

3.1

92.7

417

1254

C10AA04

ATC

fluvastatin; oral

3.2

92.5

386

1109

IGY02

NOMESCO Finland

Psychiatric monitoring contact

11.4

92.5

102

R06.1

ICD-10 Finland

Stridor

20.2

92.5

L01

ICPC

Neck symptom/complaint

2.1

92.4

1054

4908

N05BA12

ATC

alprazolam; oral

2.6

92.3

566

2014

I20.01

ICD-10 Finland

Unstable angina

852.9

92.2

R31

ICD-10 Finland

Unspecified haematuria

2.7

92.2

542

1888

J38.6

ICD-10 Finland

Stenosis of larynx

+∞

92.1

SPAT1104

SPAT

Monitoring of emergency patient

3.3

91.9

374

1058

R49.1

ICD-10 Finland

Aphonia

17.7

91.8

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

12.2

91.7

UJC02

NOMESCO Finland

Rigid oesophagoscopy

9.3

91.7

116

113

A46

ICD-10 Finland

Erysipelas

2.4

91.6

721

2886

NF1AA

NOMESCO Finland

Hip X-ray examination

2.8

91.0

503

1696

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

10.3

90.9

107

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.8

90.7

1689

9273

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.7

90.4

2542

15682

N07BB01

ATC

disulfiram; oral

5.5

90.3

184

307

R52.9

ICD-10 Finland

Pain, unspecified

2.5

89.8

629

2386

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

6.1

89.8

165

249

G04BD12

ATC

mirabegron; oral

2.4

89.6

671

2626

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

5.2

89.5

192

336

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

11.6

89.5

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.3

89.5

763

3161

M81.9

ICD-10 Finland

Osteoporosis, unspecified

5.0

89.4

204

377

A12BA01

ATC

potassium chloride; oral

6.3

89.4

159

232

SPAT1053

SPAT

Memory test

2.5

89.3

639

2449

M01AX17

ATC

nimesulide; oral

1.9

89.1

1493

7927

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.3

89.0

735

3004

F32.1

ICD-10 Finland

Moderate depressive episode

3.6

88.8

310

794

M70.6

ICD-10 Finland

Trochanteric bursitis

2.3

88.8

799

3386

R11

ICD-10 Finland

Nausea and vomiting

2.8

88.7

488

1641

Z01.9

ICD-10 Finland

Special examination, unspecified

3.1

88.6

394

1176

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.6

88.5

546

1948

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.4

87.7

678

2691

D21

ICPC

Swallowing problem

8.8

87.7

116

120

M03BX02

ATC

tizanidine; oral

1.6

87.6

4398

31298

B01AF01

ATC

rivaroxaban; oral

2.5

87.6

595

2224

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

87.6

792

3362

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

411.4

87.6

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

4.2

87.5

242

524

Z2445

NOMESCO Finland

Psychologist

5.3

87.3

184

317

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

+∞

87.1

FN1AD

NOMESCO Finland

CT of coronary arteries

+∞

87.1

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.3

87.0

703

2845

L88

ICPC

Rheumatoid/seropositive arthritis

5.4

86.9

180

305

P20

ICPC

Memory disturbance

2.5

86.6

594

2230

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.4

86.4

688

2766

ZX120

NOMESCO Finland

Intravenous

2.6

86.4

565

2074

R4190

NOMESCO Finland

Nutritional therapy

3.9

86.2

264

617

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.6

86.2

553

2011

K07

ICPC

Swollen ankles/oedema

4.5

86.1

224

462

L04AA13

ATC

[U] leflunomide

8.4

86.0

118

128

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

4.4

85.9

224

463

K30

ICD-10 Finland

Functional dyspepsia

2.3

85.9

738

3066

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

5.4

85.8

178

302

N03AG01

ATC

valproic acid; systemic, rectal

3.8

85.3

276

671

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

5.4

85.0

175

295

SPAT1255

SPAT

Intravenous administration of medicine

3.1

84.7

385

1164

R35

ICD-10 Finland

Polyuria

3.0

84.5

398

1228

A10AA02, ,

ATC

779.3

84.2

ZYC01

NOMESCO Finland

Remote contact by phone

3.4

84.1

324

885

M02AA07

ATC

piroxicam; topical

1.7

84.1

2262

13733

A10BB01

ATC

glibenclamide; oral

96.9

84.0

1420

FHL

Laryngomicroscopy

9.0

83.9

109

110

R4120

NOMESCO Finland

Occupational therapy

3.2

83.8

362

1062

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

83.7

1514

8212

R5110, ,

SPAT

3.1

83.5

365

1078

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.7

83.4

483

1668

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.8

83.2

461

1555

M10.9

ICD-10 Finland

Gout, unspecified

3.7

83.2

282

708

N06AX03

ATC

mianserin; oral

4.2

83.0

234

514

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.5

83.0

309

826

ZY000

NOMESCO Finland

Hospital inpatient

19.5

82.7

SPAT1234

SPAT

Support of social functional capacity

4.5

82.7

213

436

Z72.0

ICD-10 Finland

Tobacco use

6.0

82.1

151

228

Z3229

NOMESCO Finland

Other healthcare associate professional

2.8

82.1

456

1540

N02BF01

ATC

gabapentin; oral

2.7

82.1

465

1587

R52.2

ICD-10 Finland

Other chronic pain

4.1

81.7

234

520

N05AX08

ATC

risperidone; systemic

3.6

81.5

286

735

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

2.9

81.4

406

1294

N04BC05

ATC

pramipexole; oral

2.8

81.3

447

1502

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

+∞

81.1

TKC20

NOMESCO Finland

Catheterisation of bladder

3.4

81.0

312

852

A03FA02

ATC

cisapride; oral, rectal

2.8

81.0

436

1448

R1260

NOMESCO Finland

Evaluation of communicative skills

7.9

80.8

116

133

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

11.0

80.6

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

5.4

80.5

165

277

B01AE07

ATC

dabigatran etexilate; oral

5.9

80.4

152

236

F41.09

ICD-10 Finland

UNS Panic Syndrome

6.7

80.2

134

183

M35.3

ICD-10 Finland

Polymyalgia rheumatica

5.5

80.2

161

265

F10.24

ICD-10 Finland

Alcohol depence active use

37.5

80.0

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

79.9

1577

8764

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

6.2

79.9

143

210

N05BE01

ATC

buspirone; oral

6.6

79.8

135

187

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.7

79.7

1716

9778

B01AF03

ATC

edoxaban; oral

13.9

79.3

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

79.1

3724

25827

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.8

78.9

187

357

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

12.1

78.9

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.1

78.7

872

4003

C02AC05

ATC

moxonidine; oral

4.7

78.6

192

376

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.9

78.3

240

561

JN4AD

NOMESCO Finland

Body CT examination

2.4

78.3

616

2460

S29

ICPC

Skin symptom/complaint other

1.9

77.9

1181

6045

J34.2

ICD-10 Finland

Deviated nasal septum

3.0

77.9

376

1176

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

13.7

77.7

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

3.0

77.6

366

1130

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.0

77.4

367

1136

C10AA03

ATC

pravastatin; oral

3.2

77.3

320

914

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

+∞

77.1

A10BJ05

ATC

dulaglutide; parenteral

+∞

77.1

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.0

77.0

362

1115

M79.1

ICD-10 Finland

Myalgia

2.0

76.9

927

4387

ZX114

NOMESCO Finland

Intramuscular

5.8

76.8

147

231

R01AD58

ATC

fluticasone, combinations; nasal

1.7

76.7

1773

10289

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.9

76.5

379

1203

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

5.1

76.2

167

298

N07BA03

ATC

varenicline; oral

3.2

76.0

327

956

N17

ICPC

Vertigo/dizziness

2.3

75.9

671

2815

UGB02

NOMESCO Finland

Tracheoscopy

30.5

75.7

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

356.1

75.6

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.0

75.6

169

307

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

9.0

75.4

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

44.2

75.4

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

696.7

75.2

160

Kela drug reimbursment

exenatide

+∞

75.0

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

+∞

75.0

QA1S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in head

10.4

74.9

X58

ICD-10 Finland

Exposure to other specified factors

2.0

74.6

936

4489

XA800

NOMESCO Finland

Neuropsychological investigation

3.9

74.6

227

528

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

239.3

74.2

K80

ICPC

Cardiac arrhythmia NOS

2.7

73.8

412

1394

A12AA04

ATC

calcium carbonate; oral

10.0

73.8

H04AA01

ATC

glucagon; nasal, parenteral

146.9

73.7

C08DA01

ATC

verapamil; systemic

4.3

73.7

197

415

A99

ICPC

Disease/condition unspecnature/site

2.4

73.7

542

2098

I44.2

ICD-10 Finland

Atrioventricular block, complete

7.9

73.6

106

122

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.5

73.6

264

688

UJF92

NOMESCO Finland

Capsular endoscopy

7.0

73.6

118

154

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

6.5

73.5

125

174

R06AX27

ATC

desloratadine; oral

1.7

73.3

2055

12522

K59.1

ICD-10 Finland

Functional diarrhoea

3.3

73.3

296

833

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

13.9

73.2

C03AA03

ATC

hydrochlorothiazide; oral

2.8

73.1

395

1314

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

145.1

72.8

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.7

72.5

424

1469

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

13.6

72.4

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

11.1

72.3

M01CB01

ATC

sodium aurothiomalate; parenteral

36.9

72.3

R29

ICPC

Respiratory symptom/complaint other

2.6

72.1

442

1569

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

71.9

2087

12820

T82

ICPC

Obesity

4.5

71.9

183

371

U04

ICPC

Incontinence urine

3.5

71.8

260

682

M01AE02

ATC

naproxen; oral, rectal

1.5

71.6

3871

27453

N30.0

ICD-10 Finland

Acute cystitis

2.0

71.6

953

4662

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

71.6

1562

8899

E83.51

ICD-10 Finland

Hypocalcemia

11.1

71.5

XKD06

NOMESCO Finland

Physiologic investigation of micturition

4.7

71.4

172

333

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

71.3

3111

21030

S06.0

ICD-10 Finland

Concussion

2.3

71.3

591

2411

PA6AD

NOMESCO Finland

CT of neck arteries

4.8

71.3

169

323

C01CA24

ATC

epinephrine; parenteral

2.5

71.2

480

1784

C08CA05

ATC

nifedipine; systemic

3.2

71.1

305

890

106

Kela drug reimbursment

Hypoparathyroidism

14.2

71.1

K99

ICPC

Cardiovascular disease other

7.1

70.8

112

144

GD6AD

NOMESCO Finland

CT of chest and neck

13.0

70.7

K51.5

ICD-10 Finland

Left sided colitis

82.7

70.6

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

6.3

70.5

124

179

J96.1

ICD-10 Finland

Chronic respiratory failure

6.6

70.3

119

165

SPAT1312

SPAT

General health counselling

1.7

70.2

1891

11385

N03AF01

ATC

carbamazepine; oral, rectal

3.3

70.2

279

777

Z02.7

ICD-10 Finland

Issue of medical certificate

2.8

70.0

377

1251

R05FA02

ATC

opium derivatives and expectorants; systemic

1.6

69.9

2627

17143

C08CA02

ATC

felodipine; oral

2.7

69.9

415

1449

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.3

69.9

277

770

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.6

69.9

245

629

A10AA01, ,

ATC

328.5

69.7

XF640, ,

NOMESCO Finland

5.7

69.6

135

215

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.6

69.5

245

631

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

69.3

2606

16999

Z01.1

ICD-10 Finland

Examination of ears and hearing

2.0

69.3

920

4493

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

7.0

69.3

110

142

R20.2

ICD-10 Finland

Paraesthesia of skin

2.5

69.3

458

1686

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

641.8

69.2

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

69.2

4939

37124

P99

ICPC

Psychological disorders other

6.5

69.1

118

165

WX140

NOMESCO Finland

Parabulbar anesthesy

4.4

69.1

183

383

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.4

68.9

257

687

RD210, ,

NOMESCO Finland

7.2

68.8

107

135

F60.9

ICD-10 Finland

Personality disorder, unspecified

19.8

68.7

K50.9

ICD-10 Finland

Crohn disease, unspecified

323.9

68.7

ENC30

NOMESCO Finland

Plastic operation of pharynx

12.9

68.5

N06AA12

ATC

doxepin; systemic

3.6

68.3

236

600

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

3.8

68.2

215

513

J01DA06

ATC

[U] cefuroxime

1.9

67.9

967

4833

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

6.0

67.9

125

189

A07EA02

ATC

hydrocortisone; rectal

8.9

67.8

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

319.3

67.7

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

8.1

67.7

106

P06

ICPC

Sleep disturbance

2.2

67.6

650

2817

H25.0

ICD-10 Finland

Senile incipient cataract

3.2

67.4

281

806

K91

ICPC

Cerebrovascular disease

16.2

67.2

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

4.6

67.0

166

329

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

11.1

67.0

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.5

67.0

454

1691

M35.7

ICD-10 Finland

Hypermobility syndrome

12.4

66.9

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.7

66.9

379

1292

K02.1

ICD-10 Finland

Caries of dentine

1.5

66.3

3910

28065

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

4.5

66.2

167

336

M01AH02

ATC

rofecoxib; oral

2.1

66.0

726

3312

AN3

Balloon angioplasty and metallic stent

+∞

66.0

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

+∞

66.0

H53.1

ICD-10 Finland

Subjective visual disturbances

2.5

66.0

432

1582

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

4.5

66.0

167

337

A01AB04

ATC

amphotericin B; local oral

3.1

65.8

297

893

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

9.7

65.7

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

15.9

65.6

I95.1

ICD-10 Finland

Orthostatic hypotension

5.1

65.6

143

254

SPAT1211

SPAT

Application of soft bandage

2.4

65.4

497

1950

M54.2

ICD-10 Finland

Cervicalgia

2.3

65.4

522

2093

D01

ICPC

Abdominal pain/cramps general

2.1

65.4

719

3280

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

5.0

65.2

145

262

N18

ICPC

Paralysis/weakness

8.0

65.1

106

TGC00

NOMESCO Finland

Bronchial lavation

4.6

65.1

163

326

XX3DW

NOMESCO Finland

Time consuming IT work

2.1

65.1

728

3342

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

+∞

65.0

N05AN01

ATC

lithium; oral

9.7

65.0

K29.3

ICD-10 Finland

Chronic superficial gastritis

4.3

64.9

176

375

A02BA04

ATC

nizatidine; systemic

2.6

64.8

410

1477

N06AB05

ATC

paroxetine; oral

3.0

64.6

299

912

R03BC03

ATC

nedocromil; inhalant

2.3

64.5

504

2002

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.0

64.4

295

895

K22.1

ICD-10 Finland

Ulcer of oesophagus

8.2

64.3

100

D07AC01

ATC

betamethasone; topical

1.6

64.2

2234

14258

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.6

64.2

393

1393

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

5.3

64.1

134

229

N05BA02

ATC

chlordiazepoxide; systemic

6.8

63.9

104

138

P01

ICPC

Feeling anxious/nervous/tense

2.2

63.6

614

2663

K92.1

ICD-10 Finland

Melaena

3.4

63.5

239

643

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

4.2

63.4

176

382

A29

ICPC

General symptom/complaint other

2.1

63.1

678

3064

C09CA06

ATC

candesartan; oral

1.7

63.1

1405

8014

F43.1

ICD-10 Finland

Post-traumatic stress disorder

4.9

62.9

144

267

Z00.0

ICD-10 Finland

General medical examination

1.8

62.8

1171

6354

L04AA06

ATC

mycophenolic acid; systemic

7.3

62.7

119

IGY99

NOMESCO Finland

Other psychiatric treatment contact

9.3

62.4

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

6.7

62.4

103

139

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

24.1

62.3

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

3.9

62.2

192

451

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.8

62.2

320

1036

I47.2

ICD-10 Finland

Ventricular tachycardia

124.9

62.1

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

10.5

62.0

A10BG03

ATC

pioglitazone; oral

105.6

62.0

E86

ICD-10 Finland

Volume depletion

6.5

61.9

105

146

E04.0

ICD-10 Finland

Nontoxic diffuse goitre

6.3

61.7

108

155

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

5.5

61.5

124

205

N06AG02

ATC

moclobemide; oral

3.6

61.5

215

551

R60.9

ICD-10 Finland

Oedema, unspecified

3.0

61.4

293

910

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

6.6

61.2

103

142

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

10.7

61.1

H03BB01

ATC

carbimazole; oral

2.8

61.1

317

1031

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

61.0

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.8

60.9

193

462

SPAT1281

SPAT

Other administrative function

2.5

60.9

412

1532

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

11.7

60.9

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

19.2

60.6

XCK00

NOMESCO Finland

Perimetry

2.9

60.6

308

990

WX723

NOMESCO Finland

CPAP therapy

3.3

60.5

235

645

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

60.3

1379

7913

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

11.5

60.1

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.5

60.1

213

551

Single vessel balloon catheter extension

+∞

60.0

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

59.7

1252

7016

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.9

59.6

293

925

N05BA06

ATC

lorazepam; systemic, sublingual

3.4

59.5

230

629

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

25.4

59.5

R12

ICD-10 Finland

Heartburn

2.3

59.4

494

2014

L08

ICPC

Shoulder symptom/complaint

1.7

59.4

1298

7353

M05BX04

ATC

denosumab; parenteral

2.8

59.1

320

1064

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.7

59.1

344

1188

K59.0

ICD-10 Finland

Constipation

2.8

59.1

307

999

L13

ICPC

Hip symptom/complaint

1.8

59.0

1032

5486

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

+∞

59.0

K50.8

ICD-10 Finland

Other Crohn disease

+∞

59.0

WZA90

NOMESCO Finland

Other medical or dental certificate

1.7

59.0

1406

8151

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.4

58.9

218

580

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

16.5

58.9

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.2

58.7

535

2266

R74

ICPC

Upper respiratory infection acute

1.6

58.7

2097

13410

S22.3

ICD-10 Finland

Fracture of rib

2.5

58.6

392

1450

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

189.9

58.5

XG405

NOMESCO Finland

Education on PEF monitoring

5.5

58.5

117

192

N40

ICD-10 Finland

Hyperplasia of prostate

1.8

58.3

1013

5373

R00.2

ICD-10 Finland

Palpitations

2.3

58.3

475

1920

J96.0

ICD-10 Finland

Acute respiratory failure

10.4

58.2

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

21.2

58.2

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.3

58.2

500

2067

N18.8

ICD-10 Finland

Other chronic renal failure

6.8

58.0

127

177

Kela drug reimbursment

Insulin glargine 300 U / ml

+∞

58.0

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.6

58.0

200

508

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

18.1

57.9

R49

ICD-10 Finland

Voice disturbances

11.6

57.9

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.4

57.8

414

1580

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

5.1

57.6

125

221

J01DA09

ATC

[U] cefadroxil

1.6

57.6

1694

10343

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.8

57.6

297

962

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

3.1

57.5

254

754

D11

ICPC

Diarrhoea

2.0

57.5

675

3148

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

7.7

57.2

V03AA01, ,

ATC

9.7

57.2

JN4BD

NOMESCO Finland

Extensive body CT

2.0

57.2

654

3021

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.3

57.1

153

323

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

12.7

57.1

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

+∞

57.0

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

5.4

56.8

116

194

U05

ICPC

Urination problems other

3.1

56.8

256

769

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.1

56.6

243

709

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

18.8

56.6

P74

ICPC

Anxiety disorder/anxiety state

3.7

56.5

185

453

XJC10

NOMESCO Finland

Oesophageal pH monitoring

23.3

56.5

R06.4

ICD-10 Finland

Hyperventilation

5.7

56.4

109

173

ZXD20

NOMESCO Finland

Day surgery

1.9

56.3

828

4167

L12

ICPC

Hand/finger symptom/complaint

1.8

56.3

972

5142

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.9

56.3

274

860

N06AX22

ATC

agomelatine; oral

6.1

56.2

102

152

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

4.7

56.1

136

265

Coronary artery bypass surgery

+∞

56.0

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.5

55.9

205

542

PA7BD

NOMESCO Finland

CT angiography of neck and brain

6.7

55.8

124

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.7

55.7

185

458

R00.1

ICD-10 Finland

Bradycardia, unspecified

4.7

55.5

134

260

U02

ICPC

Urinary frequency/urgency

1.9

55.5

797

3980

SPAT1059

SPAT

Spirometry at the office

2.9

55.5

274

867

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.4

55.4

207

554

K05.31

ICD-10 Finland

Periodontitis pronounced

2.1

55.4

576

2568

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.7

55.3

1165

6523

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

22.1

55.3

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

55.3

1742

10798

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.0

55.2

625

2875

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.9

55.2

267

835

WX730

NOMESCO Finland

Conventional respirator

7.1

55.1

109

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.9

55.1

754

3706

SPAT1054

SPAT

Examination of peripheral nervous system

13.9

55.1

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

4.6

55.1

136

269

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

+∞

55.0

R63.4

ICD-10 Finland

Abnormal weight loss

3.3

55.0

218

606

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

6.8

54.8

118

E03.89

ICD-10 Finland

Other specified hypothyroidism

3.0

54.8

258

795

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

5.4

54.6

111

185

K29

ICPC

Cardiovascular sympt/complt other

3.5

54.5

193

499

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

504.6

54.3

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

11.0

54.2

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.5

54.2

194

505

M01AC06

ATC

meloxicam; systemic, rectal

1.5

54.2

2256

14863

M01AB05

ATC

diclofenac; systemic, rectal

1.5

54.2

4494

33923

N05AB01

ATC

dixyrazine; systemic

11.3

54.1

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

12.6

54.1

E66

ICD-10 Finland

Obesity

3.0

53.9

244

735

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.8

53.8

169

402

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.1

53.6

237

704

L95

ICPC

Osteoporosis

3.5

53.6

194

509

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

7.4

53.5

C07AB03

ATC

atenolol; systemic

3.1

53.5

230

672

H02AB09

ATC

hydrocortisone; systemic

4.2

53.3

150

329

TJD20

NOMESCO Finland

Change of gastrostomy tube

12.0

53.3

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

15.8

53.3

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

495.5

53.3

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

92.0

53.3

J01FA15

ATC

telithromycin; oral

2.0

53.2

658

3123

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

53.2

444

1812

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.6

53.2

334

1198

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

3.4

52.8

202

549

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

9.6

52.7

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.9

52.6

252

784

E87.6

ICD-10 Finland

Hypokalaemia

4.1

52.5

151

337

EBA00

NOMESCO Finland

Extraction of tooth

1.5

52.5

2055

13345

K50.0

ICD-10 Finland

Crohn disease of small intestine

131.1

52.4

W19

ICD-10 Finland

Unspecified fall

2.1

52.4

506

2191

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

7.7

52.4

N19

ICD-10 Finland

Unspecified kidney failure

4.5

52.3

132

266

F32

ICD-10 Finland

Depressive episode

3.0

52.1

244

749

E21.0

ICD-10 Finland

Primary hyperparathyroidism

4.6

52.1

128

252

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

6.7

52.1

116

FL1AC

NOMESCO Finland

Left cardioangiography

+∞

52.0

A11CC02

ATC

dihydrotachysterol; oral

18.9

52.0

R01AD01

ATC

beclometasone; nasal

1.7

51.9

1004

5482

R06AX22

ATC

ebastine; oral

1.7

51.9

1155

6554

WX882

NOMESCO Finland

High dependency care

4.2

51.9

143

309

TK800

NOMESCO Finland

Hemodialysis

6.4

51.6

126

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

62.2

51.5

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

4.5

51.3

129

259

S01BC05

ATC

ketorolac; ophthalmic

4.5

51.2

131

267

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

4.4

51.1

135

282

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

51.0

1414

8479

A08

ICPC

Swelling

3.0

51.0

230

691

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

+∞

51.0

J01EA01

ATC

trimethoprim; systemic

1.6

51.0

1518

9260

SPAT1081

SPAT

Cardiorespiratory global assessment

2.9

50.9

253

803

WX199

NOMESCO Finland

Other local analgesia

4.1

50.9

145

321

SFA10

NOMESCO Finland

One-surface restoration

1.4

50.9

3562

25901

A10BX01

ATC

guar gum; oral

4.8

50.9

119

225

XFE00

NOMESCO Finland

Epicardial ultrasonography

6.4

50.8

125

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

5.0

50.7

113

205

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

3.1

50.6

227

680

R03DC01

ATC

zafirlukast; oral

4.9

50.6

117

219

DJD20

NOMESCO Finland

Plastic repair of septum of nose

3.0

50.5

239

738

P29

ICPC

Psychological sympt/compl other

2.6

50.5

302

1057

QDB10, ,

SPAT

6.2

50.4

132

K29.7

ICD-10 Finland

Gastritis, unspecified

3.3

50.4

195

534

A10BH02

ATC

vildagliptin; oral

468.1

50.3

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

16.0

50.3

N06AX05

ATC

trazodone; oral

4.9

50.2

114

210

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.7

50.2

289

992

B01AB04

ATC

dalteparin; parenteral

2.6

50.2

298

1039

U07

ICPC

Urine symptom/complaint other

2.3

50.1

392

1556

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

3.8

50.0

161

390

K50.1

ICD-10 Finland

Crohn disease of large intestine

+∞

50.0

A03CA02

ATC

clidinium and psycholeptics; oral

2.6

50.0

307

1089

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

7.5

49.9

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

14.4

49.9

F60.5

ICD-10 Finland

Anankastic personality disorder

10.5

49.9

N06AB08

ATC

fluvoxamine; oral

4.3

49.7

132

277

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.2

49.7

203

575

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

5.5

49.7

162

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

9.0

49.6

GBB13

NOMESCO Finland

Revision of tracheostomy

24.5

49.5

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.6

49.5

308

1099

WX725

NOMESCO Finland

Noninvasive ventilation

2.5

49.5

336

1250

M01AB55

ATC

diclofenac, combinations; oral

2.5

49.5

340

1272

S21

ICPC

Skin texture symptom/complaint

1.8

49.2

810

4214

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

2.9

49.0

239

751

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

49.0

TFP35

NOMESCO Finland

Electroanatomical mapping

13.4

48.9

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

12.0

48.8

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.6

48.8

166

418

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

48.7

4563

34889

WX320

NOMESCO Finland

Spinalanesthesy

1.6

48.6

1370

8240

G04BD08

ATC

solifenacin; oral

2.5

48.5

335

1257

M47.9

ICD-10 Finland

Spondylosis, unspecified

3.3

48.4

192

534

I71.01

ICD-10 Finland

Aneurysm of the descending aorta

22.8

48.3

K08.3

ICD-10 Finland

Retained dental root

2.3

48.3

387

1551

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.3

48.3

194

544

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

48.3

1795

11492

GD1LA

NOMESCO Finland

10.8

48.2

L86

ICPC

Back syndrome with radiating pain

2.5

48.2

330

1233

F31.8

ICD-10 Finland

Other bipolar affective disorders

7.9

48.2

A02BX02

ATC

sucralfate; oral

3.0

48.1

218

657

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.9

48.0

678

3361

AA1

Conventional CABG

+∞

48.0

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

48.0

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

7.0

48.0

L02

ICPC

Back symptom/complaint

2.0

48.0

583

2747

GD2SN

NOMESCO Finland

Lung ventilation SPECT

15.9

48.0

250, ,

Kela drug reimbursment

230.6

48.0

SPAT1252

SPAT

Overall medication plan or its review

2.7

47.9

261

871

K51.8

ICD-10 Finland

Other ulcerative colitis

156.5

47.7

R06AE09

ATC

levocetirizine; oral

1.7

47.7

982

5448

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

5.3

47.6

100

172

Z51.5

ICD-10 Finland

Palliative care

2.2

47.4

440

1875

R04

ICPC

Breathing problem other

3.1

47.4

210

625

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.7

47.3

266

902

I95.9

ICD-10 Finland

Hypotension, unspecified

7.5

47.3

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.7

47.3

903

4905

K22.2

ICD-10 Finland

Oesophageal obstruction

7.7

47.2

WX780

NOMESCO Finland

Remote monitoring CPAP

3.0

47.1

220

675

G04CB01

ATC

finasteride; oral

2.1

47.0

472

2073

P15

ICPC

Chronic alcohol abuse

5.4

47.0

164

A10BX07

ATC

[U] liraglutide

+∞

47.0

C09BA02

ATC

enalapril and diuretics; systemic

2.5

46.9

324

1215

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

7.4

46.8

WX704

NOMESCO Finland

Intubation

2.1

46.8

487

2168

Z01.2

ICD-10 Finland

Dental examination

1.4

46.8

2977

21158

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

2.6

46.8

295

1060

A10AD05

ATC

insulin aspart; parenteral

153.5

46.7

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.4

46.6

330

1252

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

16.5

46.6

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

46.6

1636

10333

M01AX05

ATC

glucosamine; oral

1.7

46.3

998

5600

WW200

NOMESCO Finland

Immunization

3.5

46.3

164

424

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.8

46.3

858

4619

XKC03

NOMESCO Finland

Water cystometry

3.4

46.2

171

455

M10.0

ICD-10 Finland

Idiopathic gout

4.0

46.2

137

313

-50

ICPC

Medication/prescr/renewal

3.1

46.1

202

597

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.8

46.1

147

354

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.5

46.0

314

1171

NHQ40

NOMESCO Finland

Amputation of toe

10.6

46.0

H36.00

ICD-10 Finland

Diabetic background retinopathy

+∞

46.0

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

+∞

46.0

E10

ICD-10 Finland

Type 1 diabetes mellitus

221.2

46.0

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

16.8

45.9

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.9

45.8

140

327

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

150.5

45.8

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.8

45.7

698

3545

E000001, ,

ATC

1.6

45.7

1191

7016

R01AD05

ATC

budesonide; nasal

2.0

45.7

504

2293

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

45.7

4469

34233

F32.8

ICD-10 Finland

Other depressive episodes

7.7

45.7

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

3.7

45.6

151

373

L16

ICPC

Ankle symptom/complaint

1.9

45.5

634

3127

KED33

NOMESCO Finland

Transurethral incision of prostate

7.1

45.5

A06AC51

ATC

ispaghula, combinations; oral

2.6

45.4

278

984

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

422.6

45.4

WX290

NOMESCO Finland

Other blockage of nerve

1.4

45.3

2966

21151

C10AC01

ATC

colestyramine; oral

3.8

45.2

141

334

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.6

45.1

266

924

E03

ICD-10 Finland

Other hypothyroidism

2.2

45.0

397

1656

E04.1

ICD-10 Finland

Nontoxic single thyroid nodule

3.5

44.9

162

424

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

7.5

44.7

C07AB08

ATC

celiprolol; oral

4.7

44.7

108

210

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

5.8

44.7

133

M54.6

ICD-10 Finland

Pain in thoracic spine

2.1

44.7

435

1888

G04CA01

ATC

alfuzosin; oral

1.9

44.6

610

2989

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

5.5

44.6

149

L04

ICPC

Chest symptom/complaint

2.3

44.6

352

1402

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

44.6

872

4764

N30.9

ICD-10 Finland

Cystitis, unspecified

2.4

44.5

330

1278

SAA04

NOMESCO Finland

Special examination of mouth

2.4

44.5

330

1278

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

7.2

44.4

SPAT1231

SPAT

Assessment of adjustments needed in living environment

6.6

44.4

101

F41.00

ICD-10 Finland

Moderate panic disorder

12.6

44.3

X57

ICD-10 Finland

Unspecified privation

3.8

44.1

142

344

H53.2

ICD-10 Finland

Diplopia

3.3

44.1

169

460

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.0

44.1

205

627

J01MA01

ATC

ofloxacin; systemic

2.1

44.0

476

2149

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

+∞

44.0

T78.4

ICD-10 Finland

Allergy, unspecified

2.5

44.0

296

1097

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

6.0

43.9

123

TKC22

NOMESCO Finland

Catheterisation instruction

5.3

43.9

158

ACC51

NOMESCO Finland

Release of median nerve

2.1

43.8

439

1926

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

4.3

43.8

117

247

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

20.3

43.7

K85

ICPC

Elevated blood pressure

1.7

43.6

810

4359

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

12.2

43.5

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.1

43.5

192

570

SFA20

NOMESCO Finland

Two-surface restoration

1.4

43.4

3859

28953

R51

ICD-10 Finland

Headache

2.3

43.2

341

1357

C09CA03

ATC

valsartan; oral

2.1

43.2

428

1869

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

21.0

43.1

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.2

43.0

182

527

162

Kela drug reimbursment

liraglutide

+∞

43.0

A10BG02

ATC

rosiglitazone; oral

+∞

43.0

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.8

43.0

221

715

I71.00

ICD-10 Finland

Dissecting aneurysm of aorta (ruptured) [any part]

11.5

42.8

SPAT1139

SPAT

Nutrition survey

3.7

42.8

139

339

I71.09

ICD-10 Finland

Aortic dissection [regardless of location]

12.3

42.8

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.8

42.8

217

697

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

88.5

42.7

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

42.7

1324

8115

XKD03

NOMESCO Finland

Urethral pressure profilometry

3.7

42.6

139

340

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

10.0

42.5

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.1

42.5

121

268

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.7

42.5

140

345

M01AH05

ATC

etoricoxib; oral

1.4

42.4

4167

31740

AA5PD

NOMESCO Finland

CT examination of brain pefusion

15.0

42.4

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

4.3

42.4

113

238

C07AG02

ATC

carvedilol; oral

2.9

42.4

211

671

G04BD07

ATC

tolterodine; oral

2.8

42.3

227

751

M54

ICD-10 Finland

Dorsalgia

1.8

42.3

727

3823

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

7.3

42.3

D12

ICPC

Constipation

3.2

42.2

177

510

K04

ICPC

Palpitations/awareness of heart

2.5

42.2

275

1004

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

13.5

42.1

J43.9

ICD-10 Finland

Emphysema, unspecified

5.9

42.1

119

AP1

Catheterization of the left side of the heart

203.0

42.0

K07.60

ICD-10 Finland

Snapping jaw

2.3

42.0

345

1397

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

42.0

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

+∞

42.0

L29

ICPC

Musculoskeletal sympt/complt other

2.0

41.9

470

2150

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

64.6

41.9

R28

ICPC

Limited function/disability (R)

5.6

41.9

132

B03BA03

ATC

hydroxocobalamin; parenteral

2.7

41.9

233

786

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

4.0

41.9

125

287

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

106.1

41.8

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

10.0

41.8

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.9

41.6

595

2958

CJ2M4

NOMESCO Finland

Scans and measurement printouts for intraocular lens power calculation

14.4

41.5

A97

ICPC

No disease

1.6

41.5

1002

5780

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

10.6

41.5

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.8

41.5

220

724

UGC02

NOMESCO Finland

Rigid bronchoscopy

10.9

41.4

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

3.5

41.4

150

394

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

4.1

41.4

117

258

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.9

41.3

124

286

XA402

NOMESCO Finland

ENMG

3.2

41.3

166

466

H26.9

ICD-10 Finland

Cataract, unspecified

7.7

41.3

G04BD04

ATC

oxybutynin; oral, transdermal

2.6

41.2

247

865

J47

ICD-10 Finland

Bronchiectasis

4.4

41.2

106

217

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

9.8

41.1

XJH00

NOMESCO Finland

Transanal ultrasonography

2.5

41.0

277

1028

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.7

41.0

238

821

C08CA07

ATC

nisoldipine; oral

18.6

40.9

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

10.3

40.9

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

72.3

40.9

DHB50

NOMESCO Finland

Turbinoplasty

3.2

40.8

166

469

R06AX13

ATC

loratadine; oral

1.7

40.8

954

5457

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

13.9

40.7

SPAT1257

SPAT

Teaching of medicine inhalation technique

3.2

40.6

163

457

I20.9

ICD-10 Finland

Angina pectoris, unspecified

12.6

40.5

C09DA01

ATC

losartan and diuretics; oral

2.0

40.5

497

2346

M13.9

ICD-10 Finland

Arthritis, unspecified

2.2

40.5

358

1495

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

377.0

40.4

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.8

40.4

204

654

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.6

40.4

252

901

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.9

40.3

194

605

Catheterization and pressure measurement of the left side of the heart

50.2

40.3

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

5.5

40.2

134

B97.7

ICD-10 Finland

Papillomavirus as the cause of diseases classified to other chapters

7.3

40.2

F33

ICD-10 Finland

Recurrent depressive disorder

4.5

40.1

102

207

L15

ICPC

Knee symptom/complaint

1.5

40.1

1341

8345

K74

ICPC

Ischaemic heart dis with angina

61.8

40.0

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

40.0

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.3

39.9

310

1225

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

8.3

39.9

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

11.0

39.9

A10AD01

ATC

insulin (human); parenteral

83.1

39.8

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

3.8

39.8

128

310

NH3EA

NOMESCO Finland

Feet X-ray examination with load

4.6

39.8

190

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.8

39.8

125

298

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.0

39.7

483

2273

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

8.0

39.7

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.6

39.6

231

798

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

6.6

39.6

GD1UN

NOMESCO Finland

Lung circulation SPECT

16.2

39.6

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

9.8

39.6

N06AA06

ATC

trimipramine; systemic

4.0

39.5

116

263

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.7

39.5

128

312

R49.02

ICD-10 Finland

Spasmodic dysphonia

15.2

39.4

R4110, ,

SPAT

2.0

39.4

462

2147

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

3.8

39.4

122

288

K22.7

ICD-10 Finland

Barrett oesophagus

6.7

39.3

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.8

39.3

606

3083

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.3

39.2

105

222

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.4

39.2

134

I49.3

ICD-10 Finland

Ventricular premature depolarization

2.2

39.2

362

1538

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.8

39.2

124

297

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.1

39.1

168

491

G72.8

ICD-10 Finland

Other specified myopathies

7.4

39.1

R32

ICD-10 Finland

Unspecified urinary incontinence

3.6

39.1

132

331

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.4

39.0

273

1030

ZXC60

NOMESCO Finland

Application of heat

4.8

39.0

172

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.5

38.9

201

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.9

38.8

110

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

4.0

38.7

115

263

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

38.7

1505

9659

H53.4

ICD-10 Finland

Visual field defects

4.6

38.7

191

JF1AD

NOMESCO Finland

Small bowel CT

10.4

38.5

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

14.5

38.5

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.0

38.5

446

2064

H26.2

ICD-10 Finland

Complicated cataract

358.8

38.4

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

11.1

38.4

J01MA06

ATC

norfloxacin; oral

1.7

38.3

755

4125

AS4

Physiological pacemaker insertion DDD (R)

11.9

38.3

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.5

38.2

136

353

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

38.1

1215

7475

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

+∞

38.0

C09DX04

ATC

valsartan and sacubitril; oral

+∞

38.0

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

+∞

38.0

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

38.0

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

+∞

38.0

280

Kela drug reimbursment

Clopidogrel

+∞

38.0

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.0

38.0

171

514

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.9

37.9

482

2302

CL2S4, ,

SPAT

97.0

37.9

G04CA52

ATC

tamsulosin and dutasteride; systemic

2.0

37.8

420

1914

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.4

37.8

278

1073

M02AA10

ATC

ketoprofen; topical

1.6

37.8

886

5066

K92.0

ICD-10 Finland

Haematemesis

4.2

37.8

103

221

RS221, ,

NOMESCO Finland

5.6

37.5

120

C05AA08

ATC

fluocortolone; rectal, topical

1.7

37.5

793

4414

R01AD11

ATC

triamcinolone; nasal

1.9

37.5

535

2655

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

349.7

37.4

J39.8

ICD-10 Finland

Other specified diseases of upper respiratory tract

9.6

37.4

N19

ICPC

Speech disorder

5.8

37.4

111

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.9

37.4

112

258

H01

ICPC

Ear pain/earache

1.8

37.2

673

3587

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

180.3

37.1

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.8

37.1

578

2947

M05BA07

ATC

risedronic acid; oral

3.6

37.1

126

317

S01ED51

ATC

timolol, combinations; ophthalmic

2.3

37.1

289

1144

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

+∞

37.0

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

94.7

37.0

4CJ01, ,

NOMESCO Finland

8.8

36.6

F31

ICD-10 Finland

Bipolar affective disorder

8.8

36.6

S80.0

ICD-10 Finland

Contusion of knee

2.0

36.6

435

2030

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.9

36.6

112

262

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

3.1

36.6

162

482

C10AA02

ATC

lovastatin; oral

3.3

36.6

146

408

SFA30

NOMESCO Finland

Three-surface restoration

1.4

36.6

2607

18667

SPAT1360

SPAT

Extensive global examination

2.1

36.5

343

1467

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

340.6

36.4

J01DC02

ATC

cefuroxime; systemic

2.1

36.4

351

1516

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.8

36.4

598

3099

M01AB01

ATC

indometacin; systemic, rectal

2.2

36.4

337

1433

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

5.8

36.3

108

Z01.7

ICD-10 Finland

Laboratory examination

1.7

36.3

820

4642

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.7

36.3

698

3786

DQB70

NOMESCO Finland

Total excision of vocal cord

175.8

36.2

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

64.8

36.1

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

8.7

36.1

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.0

36.1

410

1883

K01

ICPC

Heart pain

7.3

36.0

SPAT1167

SPAT

Insertion of urinary catheter

4.0

36.0

106

241

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

11.7

36.0

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

+∞

36.0

H02.3

ICD-10 Finland

Blepharochalasis

2.1

35.9

359

1573

I45.9

ICD-10 Finland

Conduction disorder, unspecified

9.7

35.9

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.9

35.8

495

2431

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.8

35.8

180

576

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

5.3

35.7

129

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.6

35.6

211

735

N05AL01

ATC

sulpiride; systemic

6.7

35.6

J05.1

ICD-10 Finland

Acute epiglottitis

10.2

35.6

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

6.1

35.5

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.0

35.5

394

1795

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.9

35.4

106

244

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

2.5

35.4

225

812

KH1AD

NOMESCO Finland

CT of urinary organs

2.7

35.3

191

635

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.2

35.3

146

417

H25.9

ICD-10 Finland

Senile cataract, unspecified

8.7

35.3

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

4.0

35.3

103

233

D06

ICPC

Abdominal pain localized other

1.9

35.2

491

2417

N29

ICPC

Neurological sympt/complt other

3.9

35.2

105

241

Z50.1

ICD-10 Finland

Other physical therapy

2.3

35.2

265

1033

D07XC01

ATC

betamethasone; topical

1.7

35.2

665

3587

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

6.5

35.2

R1250

NOMESCO Finland

Evaluation of functional capability

3.6

35.1

118

295

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

8.8

35.1

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

35.0

555

2844

K08.80

ICD-10 Finland

Toothache NOS

1.8

35.0

548

2798

J05AB01

ATC

aciclovir; systemic

1.5

35.0

1316

8369

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

35.0

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

+∞

35.0

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

+∞

35.0

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

10.0

34.9

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

3.9

34.9

107

251

S04

ICPC

Lump/swelling localized

1.8

34.9

589

3077

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

6.5

34.8

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.2

34.8

326

1392

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.4

34.8

252

966

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

8.0

34.8

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.9

34.7

170

536

130

Kela drug reimbursment

Malignant tumour

1.8

34.7

618

3278

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.9

34.6

167

522

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.4

34.6

248

946

4784A

ICD-9 Finland

Other diseases of upper respiratory tract, Polyp of vocal cord or larynx[POLYPUS PLICAE VOCALIS]

11.0

34.6

K83

ICPC

Heart valve disease NOS

12.5

34.5

N02AC04

ATC

dextropropoxyphene; oral

2.9

34.5

169

533

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

322.4

34.5

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

322.4

34.5

M54.3

ICD-10 Finland

Sciatica

2.1

34.5

325

1392

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.2

34.3

137

383

N01

ICPC

Headache

1.8

34.3

592

3112

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

4.0

34.3

101

230

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.3

34.1

278

1122

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

114.2

34.1

M03BX01

ATC

baclofen; systemic

3.9

34.1

105

247

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

87.9

34.1

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

87.9

34.1

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

15.2

34.1

F39

ICD-10 Finland

Unspecified mood [affective] disorder

5.9

34.1

-1, ,

NOMESCO Finland

1.4

34.1

1979

13651

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

+∞

34.0

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

+∞

34.0

L04AB04

ATC

adalimumab; parenteral

4.8

34.0

149

P16

ICPC

Acute alcohol abuse

6.7

33.8

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

11.5

33.8

M54.1

ICD-10 Finland

Radiculopathy

2.5

33.7

219

798

H05BX01

ATC

cinacalcet; oral

12.0

33.7

SPAT1304

SPAT

Counselling and guidance related to ageing

2.3

33.7

265

1053

R07.2

ICD-10 Finland

Precordial pain

4.2

33.7

194

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.9

33.6

429

2052

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

703

1273

5.36

319.82

2.4

1.4

8.16

3.81

ug/l

3.95

596

1079

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2583

11087

2.66

317.87

2.9

2.2

65.06

69.53

u/l

0.16

2342

10283

(3016502) Oxygen saturation in Arterial blood

942

2206

4.24

314.17

10.3

5.7

95.88

96.82

5.25

903

2117

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1567

5163

3.18

313.98

4.3

2.0

450.97

68.38

ng/l

3.78

1170

3206

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1320

3918

3.45

313.25

2.5

1.9

29.98

28.85

7.38

1277

3807

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3030

12640

2.93

307.65

2.1

1.5

96.43

99.95

pmol/l

3.25

1616

6057

(3020682) Albumin/Creatinine [Ratio] in Urine

1964

5855

3.72

307.65

3.9

2.1

8.82

7.12

mg/mmol

0.71

1224

2950

(3027801) Oxygen [Partial pressure] in Arterial blood

1059

2594

4.10

307.65

9.7

5.3

12.08

14.51

kpa

32.94

999

2482

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3022

11217

3.37

307.65

4.1

1.8

40.02

18.95

ng/l

2.93

2011

5490

(3015377) Calcium [Moles/volume] in Serum or Plasma

2884

12961

2.62

307.65

3.7

3.9

2.34

2.36

mmol/l

6.97

2512

11598

(3019309) Folate [Moles/volume] in Red Blood Cells

1490

4325

3.61

307.65

1.8

1.5

1163.28

1126.08

nmol/l

0.77

1098

3235

(3001604) Monocytes [#/volume] in Blood

4136

19197

3.08

307.65

6.2

4.0

0.58

0.54

e9/l

16.74

3683

16470

(3003396) Base excess in Arterial blood by calculation

1053

2604

4.06

307.65

9.7

5.3

1.37

0.82

mmol/l

5.44

870

2090

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4149

16936

3.68

307.65

9.0

4.8

1.21

1.22

mmol/l

22.64

3530

14430

(40768797) Stomach Pathology biopsy report

1446

4141

3.64

307.65

1.3

1.2

—

(3018010) Neutrophils/100 leukocytes in Blood

3952

19055

2.82

307.65

6.2

4.0

57.81

55.49

27.94

3714

17877

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4129

19729

2.95

307.65

7.0

6.4

10.88

11.21

umol/l

0.75

3892

18792

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1264

3081

4.22

307.65

6.0

4.6

1.05

1.02

mmol/l

2.11

1169

2867

(3019198) Lymphocytes [#/volume] in Blood

4226

20076

3.04

307.65

6.3

4.0

1.88

1.98

e9/l

2.53

3840

17659

(3024561) Albumin [Mass/volume] in Serum or Plasma

3504

14467

3.20

307.65

5.2

4.1

35.53

36.38

g/l

14.47

3231

13412

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2295

5639

4.82

307.65

3.3

1.6

1138.80

339.24

ng/l

18.15

1954

4520

(3013826) Glucose [Moles/volume] in Serum or Plasma

4519

20471

3.47

307.65

6.2

3.0

6.53

6.06

mmol/l

48.34

4302

18756

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1657

4461

3.99

307.65

4.1

3.6

0.81

0.83

mmol/l

7.21

1552

4196

(40760892) CBC W Ordered Manual Differential panel - Blood

3948

17848

3.08

307.65

6.9

4.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3909

15217

3.73

307.65

8.1

4.2

1.21

1.22

mmol/l

21.30

3579

13781

(3012516) Albumin [Mass/volume] in Urine

1897

5540

3.77

307.65

3.3

1.9

286.34

856.93

mg/l

4.19

1204

2766

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2490

8402

3.48

307.65

2.4

1.6

198.07

183.67

u/l

0.32

2350

7829

(3018418) pH of Serum or Plasma

2495

9787

2.93

307.65

5.3

3.4

7.40

0.11

537

1675

(3013115) Eosinophils [#/volume] in Blood

4275

20107

3.11

307.65

6.4

4.1

0.19

e9/l

0.94

3840

17471

(3002030) Lymphocytes/100 leukocytes in Blood

4016

19390

2.85

307.65

6.4

4.1

27.35

29.89

39.29

3772

18195

(3013650) Neutrophils [#/volume] in Blood by Automated count

4609

23632

2.95

307.65

9.7

7.6

4.16

3.75

e9/l

26.66

4103

20337

(3023368) Bacteria identified in Blood by Culture

2243

7787

3.26

307.65

4.9

3.5

—

(3009508) Creatinine [Moles/volume] in Urine

2069

6417

3.61

307.65

3.2

1.9

7.44

8.31

mmol/l

11.94

1722

5566

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2043

6704

3.38

307.65

2.4

1.6

2.92

2.67

mg/l

4.27

1729

5606

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1505

4213

3.76

307.65

2.1

1.6

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1060

2595

4.10

307.65

9.7

5.4

5.20

5.14

kpa

0.89

999

2485

(3006504) Eosinophils/100 leukocytes in Blood

3905

18386

2.89

307.65

6.4

4.1

2.83

2.92

1.45

3657

17138

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3291

15584

2.59

307.65

2.5

1.8

79.52

78.32

nmol/l

1.53

2974

14165

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5689

32451

3.38

307.65

9.1

5.9

76.50

77.11

u/l

0.36

5377

30393

(3006315) Basophils [#/volume] in Blood

4134

19235

3.07

307.65

6.3

4.0

0.04

e9/l

4.87

3682

16467

(3013707) Erythrocyte sedimentation rate by Westergren method

5564

32552

3.07

307.65

5.0

2.5

11.82

9.62

mm/h

26.78

5141

30059

(3022217) INR in Platelet poor plasma by Coagulation assay

3682

13490

3.85

307.65

15.7

4.2

1.21

1.07

inr

17.21

1071

3699

(3019069) Monocytes/100 leukocytes in Blood

3924

18524

2.89

307.65

6.7

4.3

8.48

8.37

1.40

3677

17311

(3022096) Basophils/100 leukocytes in Blood

3793

17649

2.88

307.65

6.4

4.1

0.67

0.70

1.78

3533

16383

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5701

35932

2.77

305.21

5.7

3.4

15.11

14.49

pmol/l

55.56

5237

32928

(3031040) Bacteria [#/volume] in Urine by Automated count

4879

28572

2.52

303.99

5.1

3.1

881.94

1213.71

e6/l

0.21

358

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1030

2727

3.77

288.95

2.0

1.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

969

2475

3.89

286.02

2.4

2.7

354.16

390.68

nmol/l

5.25

885

2320

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

835

1927

4.25

282.81

4.0

3.0

76.88

69.40

ng/l

1.62

722

1717

(3037467) Urinalysis macro (dipstick) panel - Urine

4950

29786

2.45

279.74

5.0

3.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1756

6559

2.83

278.19

1.6

1.3

20.03

21.17

nmol/l

1.96

1507

5512

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1017

2753

3.68

275.59

2.0

1.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1123

3299

3.42

268.30

2.7

1.8

22.76

26.26

9.65

955

2853

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

936

2440

3.79

267.61

4.6

3.6

4.53

4.61

pmol/l

1.01

848

2209

(3013512) EKG study

2305

10053

2.53

266.28

4.3

2.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

812

1919

4.14

265.95

7.1

5.2

8.86

7.41

mmol/l

7.10

773

1839

(3022948) Iron [Moles/volume] in Serum or Plasma

1273

4096

3.15

261.80

2.6

1.8

13.24

15.31

umol/l

15.06

1173

3839

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1181

3665

3.24

257.72

2.6

1.7

2.36

2.37

g/l

0.19

1082

3401

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

667

1385

4.64

257.55

4.5

3.0

5.20

5.11

kpa

1.58

634

1320

(3002173) Hemoglobin [Mass/volume] in Arterial blood

853

2142

3.90

256.77

10.9

5.9

121.70

122.50

g/l

0.49

818

2072

(3014111) Lactate [Moles/volume] in Serum or Plasma

822

2033

3.95

252.60

9.5

5.4

1.32

1.19

mmol/l

2.26

803

1979

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6405

44489

3.01

252.28

6.7

3.7

2.30

2.20

mu/l

0.10

5934

40944

(3009343) pH of Capillary blood

657

1373

4.61

251.56

4.5

3.0

7.43

0.16

137

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1979

8251

2.56

248.87

2.0

1.5

1.04

1.05

mg/l

0.08

1497

6221

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

640

1336

4.61

245.24

4.4

3.0

1.68

1.50

mmol/l

0.53

497

997

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6835

49543

3.71

243.81

19.6

7.6

22.02

24.23

mg/l

6.38

5740

34874

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3372

18043

2.23

237.46

3.3

2.3

120.15

108.36

ug/l

1.32

3124

17057

(3000991) Gas panel - Venous blood

777

1932

3.91

236.48

10.6

6.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

306

314

9.07

233.31

8.3

7.2

—

(3012544) pH of Venous blood

768

1912

3.90

233.23

4.3

3.2

7.38

7.37

—

(3019060) Gas panel - Arterial blood

612

1295

4.53

230.28

6.0

3.6

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

753

1865

3.91

230.24

4.2

3.3

5.95

5.84

kpa

1.75

728

1817

(3026008) Bacteria identified in Urine by Culture

2257

10343

2.37

228.01

3.3

2.2

—

(3002032) Base excess in Venous blood by calculation

748

1859

3.90

227.53

4.3

3.3

2.18

2.01

mmol/l

0.52

639

1587

(3044640) Blood type and Crossmatch panel - Blood

2677

13218

2.27

226.85

2.8

2.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

645

1456

4.25

223.35

3.2

1.6

160.45

72.78

ng/l

8.59

589

1284

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3705

20986

2.15

221.13

2.9

2.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

802

2134

3.66

220.92

2.9

2.4

10.19

10.46

g/l

0.69

730

1946

(3027456) Digoxin [Moles/volume] in Serum or Plasma

136

56.46

220.11

3.0

2.6

0.81

1.05

nmol/l

—

105

(3037522) Nuclear Ab [Titer] in Serum

1289

4668

2.78

211.20

1.4

1.2

548.61

396.40

titre

1.80

267

778

(3002582) Erythrocytes [#/volume] in Urine

2310

10999

2.28

210.57

3.6

2.4

67.63

84.46

e6/l

0.20

1792

7941

(3007853) Bacteria identified in Skin by Aerobe culture

1120

3777

2.95

209.21

2.0

1.4

—

(3018095) Leukocytes [#/volume] in Urine

2656

13423

2.20

208.97

4.2

2.8

61.30

77.78

e6/l

1.05

1917

8779

(3000850) Epithelial cells [#/volume] in Urine

1683

7004

2.49

207.86

2.8

2.0

4.85

5.96

e6/l

2.97

1493

6185

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

655

1580

3.98

207.12

1.7

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

2135

9963

2.29

202.94

3.5

2.4

0.27

0.37

e6/l

1.98

1638

7074

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2111

9839

2.29

200.93

2.7

1.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1768

7670

2.40

198.23

1.6

1.3

2.28

2.19

g/l

1.18

1094

4828

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

335

466

6.70

197.74

8.0

5.3

78.69

143.57

u/ml

0.87

133

156

(3042936) Bacteria identified in Isolate by Culture

1252

4618

2.72

196.99

2.1

1.6

—

(36304419) Bacteria [Presence] in Urine

2108

9895

2.27

196.61

3.4

2.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

6816

50846

3.24

196.41

21.4

7.9

139.58

139.93

mmol/l

26.51

6673

49107

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1505

6105

2.52

195.01

1.7

1.3

4774094.73

32472206.14

pmol/l

3.03

1215

5223

(3023103) Potassium [Moles/volume] in Serum or Plasma

6826

51095

3.23

192.48

21.5

8.0

3.95

3.94

mmol/l

2.63

6670

49208

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2459

12483

2.14

187.03

3.6

2.9

31.90

31.57

u/l

0.11

2326

11974

(3009445) Proteinase 3 Ab [Units/volume] in Serum

481

990

4.59

186.56

1.6

1.1

22.09

0.87

u/ml

1.09

(3027945) Reticulocytes/100 erythrocytes in Blood

875

2740

3.11

184.88

2.7

2.6

1.76

1.57

6.76

762

2468

(3024354) Oxygen [Partial pressure] in Venous blood

607

1505

3.85

184.20

3.5

2.9

4.82

4.55

kpa

1.63

585

1461

(3033658) Prothrombin time (PT) actual/Normal

2073

9887

2.22

184.10

4.6

3.0

91.05

96.39

17.80

2025

9655

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1551

6536

2.42

183.98

3.1

3.4

2.45

2.44

mmol/l

0.45

1343

5797

(3008152) Bicarbonate [Moles/volume] in Arterial blood

554

1294

4.07

182.52

8.9

4.9

25.17

24.80

mmol/l

1.56

517

1217

(3005322) IgE [Units/volume] in Serum or Plasma

841

2607

3.13

180.60

1.5

1.2

132.32

202.47

u/ml

3.52

798

2424

(3023419) Bacteria identified in Sputum by Culture

268

322

7.71

179.97

3.2

2.2

—

(3021589) Normoblasts [#/volume] in Blood

3253

18543

2.01

178.82

11.2

6.3

0.00

e9/l

0.79

2716

14893

(3028026) IgM [Mass/volume] in Serum or Plasma

621

1607

3.69

177.04

2.1

1.8

1.26

1.41

g/l

0.90

568

1467

(3026782) Osmolality of Urine

1566

6744

2.37

176.14

2.9

2.2

525.83

568.10

mosm/kgh2o

11.33

1325

5735

(3048689) Calprotectin [Mass/mass] in Stool

1130

4194

2.67

174.14

2.2

1.2

127.90

80.30

ug/g

3.61

896

3145

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1920

9058

2.21

173.66

1.3

1.2

1.70

1.80

u/ml

0.11

489

2595

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

432

865

4.69

173.08

2.8

2.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

338

544

5.79

172.78

3.1

2.4

0.32

0.34

u/ml

0.54

186

263

(3022313) Gas panel - Capillary blood

482

1061

4.29

171.55

4.7

3.1

—

(3044889) 12 lead EKG panel

4727

30958

2.00

171.49

4.4

2.3

—

(3019225) pH of Specimen

980

3414

2.81

170.46

5.0

3.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

527

1255

3.98

168.85

12.4

6.8

24.80

24.37

mmol/l

2.48

509

1233

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

557

1384

3.82

168.17

1.8

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5978

42930

2.23

165.30

6.0

2.9

39.33

36.25

mmol/mol

141.10

5510

39660

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

959

3403

2.75

160.56

3.8

5.3

237.89

246.36

u/l

0.73

905

3266

(3020630) Protein [Mass/volume] in Serum or Plasma

696

2069

3.22

159.57

2.5

3.1

66.14

67.20

g/l

2.76

629

1933

(40758558) Short blood count panel - Blood

2052

10248

2.10

158.17

7.5

6.4

—

(4200892) Spirometry reversibility

784

2518

3.00

157.52

1.5

1.3

—

(3035350) Ketones [Presence] in Urine by Test strip

3430

20549

1.92

156.63

3.9

2.5

0.00

estimate

1.08

739

3518

(3021601) Nitrite [Presence] in Urine by Test strip

3446

20783

1.90

153.06

5.1

3.5

0.00

estimate

0.35

722

3359

(3023520) Reticulocytes [#/volume] in Blood

651

1905

3.26

152.95

2.6

2.8

68.67

65.69

e9/l

1.15

494

1373

(3009261) Glucose [Presence] in Urine by Test strip

3466

20956

1.90

152.63

3.9

2.5

0.00

estimate

-0.00

707

3397

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

349

652

4.99

151.50

2.4

1.9

732.94

333.77

ug/l

0.43

329

607

(3004119) Hemoglobin [Mass/volume] in Venous blood

469

1109

3.98

151.45

3.7

2.7

127.62

131.72

g/l

2.83

450

1087

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

858

2962

2.81

150.90

2.4

2.2

0.22

g/l

1.84

812

2822

(3004588) Protein electrophoresis panel - Serum or Plasma

553

1512

3.46

144.47

2.5

2.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

377

789

4.46

142.74

1.5

1.4

137.50

227.25

titre

0.52

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

512

1349

3.58

141.44

12.6

6.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

427

991

4.04

141.30

5.0

3.1

24.88

24.91

mmol/l

0.06

396

938

(3026493) Urate [Moles/volume] in Serum or Plasma

1916

9705

2.04

139.41

2.7

2.1

1492.97

4800.21

umol/l

6.67

1663

8751

(3015736) pH of Urine

2816

16285

1.88

138.50

3.5

2.4

5.97

5.93

0.31

212

1933

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

376

817

4.29

135.67

3.2

2.7

1.50

1.13

6.74

376

809

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

431

1037

3.89

135.66

4.8

4.1

24.40

24.33

mmol/l

0.14

421

1025

(40768804) Tissue Pathology biopsy report

3436

21263

1.83

135.13

2.3

2.0

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

340

684

4.62

135.09

1.7

1.2

0.23

0.24

g/l

1.43

314

648

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

153

127

11.01

135.03

2.3

2.1

95.19

158.27

ug/min

0.37

(3015235) Bicarbonate [Moles/volume] in Capillary blood

261

416

5.79

134.55

3.2

2.4

24.92

24.69

mmol/l

0.37

254

407

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6292

47342

2.20

133.81

16.9

7.4

83.27

84.71

ml/min/173m2

6.43

5398

37369

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1493

7001

2.14

132.65

1.4

1.2

26.46

22.21

iu/ml

0.49

454

2151

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

370

808

4.27

132.61

3.2

2.7

0.63

0.67

1.28

370

803

(3000494) Fungus identified in Specimen by Culture

1115

4640

2.36

132.27

1.6

1.3

—

(3017181) Myelocytes/100 leukocytes in Blood

707

2360

2.86

131.67

3.7

3.4

0.92

1.07

0.73

243

782

(3020891) Body temperature

343

717

4.45

129.94

6.5

3.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

868

3244

2.58

129.73

3.7

2.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

344

728

4.39

128.30

1.7

1.2

1.16

1.18

g/l

0.74

319

694

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

369

825

4.17

128.21

2.4

1.8

1.40

1.96

ug/l

0.57

323

750

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4718

32432

1.82

128.12

3.6

2.2

49.80

37.66

u/l

8.75

4378

30635

(3021440) Promyelocytes/100 leukocytes in Blood

675

2256

2.85

125.21

3.7

3.4

0.15

0.13

0.27

214

679

(3018405) Lactate [Moles/volume] in Arterial blood

307

622

4.57

120.83

5.8

2.9

1.20

1.25

mmol/l

0.48

302

614

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1399

6608

2.11

120.80

1.3

1.2

14.89

2.42

u/ml

2.56

500

2665

(3002179) Metamyelocytes/100 leukocytes in Blood

642

2134

2.86

120.15

3.5

3.4

0.71

0.81

0.49

211

671

(3025159) Blasts/100 leukocytes in Blood

642

2140

2.85

119.51

3.8

3.4

0.04

0.68

1.77

179

574

(3022145) Colonoscopy Study observation

985

4049

2.36

119.36

1.3

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1300

6061

2.12

115.67

3.1

2.2

0.87

1.02

e6/l

1.14

734

3148

(3042631) Mycobacterium sp identified in Specimen

209

316

6.07

113.56

3.0

2.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6320

48500

2.08

112.64

4.9

3.1

5.88

5.48

mmol/l

119.34

5761

44775

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

689

2465

2.66

111.78

4.7

3.0

1.22

1.23

mmol/l

7.10

610

2126

(3027273) Bicarbonate [Moles/volume] in Venous blood

358

865

3.85

111.77

3.9

2.1

25.80

25.68

mmol/l

0.24

349

842

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

996

4236

2.28

111.04

2.5

2.6

7.54

8.27

umol/l

0.32

840

3730

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

298

633

4.36

110.50

1.5

1.3

—

(40761511) CBC panel - Blood by Automated count

6853

54441

2.51

110.07

17.8

7.1

—

(3021901) Oxygen saturation in Capillary blood

194

283

6.29

109.17

2.9

2.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

304

671

4.19

107.26

1.4

1.1

11.01

2.43

iu/ml

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

507

1582

3.01

105.96

1.6

1.4

—

(3000492) Spirometry study

1014

4425

2.22

105.94

1.5

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

352

876

3.73

105.31

1.8

1.6

1.67

1.41

g/l

3.89

300

733

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6910

55341

2.54

104.22

12.8

6.5

26.02

24.77

u/l

3.25

6689

53198

(3000570) Elastase.pancreatic [Mass/mass] in Stool

315

734

3.97

103.34

1.3

300.07

278.27

ug/g

0.95

180

402

(3029937) Albumin [Presence] in Urine by Test strip

1875

10348

1.83

100.44

4.5

2.7

0.00

estimate

0.10

705

3304

(1616796) Gas panel - Central venous blood

230

427

4.95

100.33

4.6

2.8

—

(40767503) Oxygen content in Capillary blood by calculation

223

405

5.06

99.75

2.8

1.9

16.68

17.05

0.49

119

184

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1222

5863

2.04

99.36

3.3

2.3

3.03

2.74

e6/l

0.41

655

2953

(4062490) Immunoglobulin typing, IgG

177

259

6.25

99.29

1.7

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

252

512

4.53

98.74

4.5

3.6

8.32

8.88

kpa

4.81

244

497

(3024980) IgG subclass 4 [Mass/volume] in Serum

229

430

4.90

98.59

1.7

1.3

0.62

0.88

g/l

2.17

161

326

(3028192) IgG subclass 2 [Mass/volume] in Serum

176

262

6.15

97.09

1.6

1.2

2.73

3.16

g/l

2.04

116

176

(3024139) IgG subclass 3 [Mass/volume] in Serum

176

263

6.12

96.72

1.6

1.2

0.35

0.42

g/l

1.80

117

174

(3027135) IgG subclass 1 [Mass/volume] in Serum

176

264

6.10

96.36

1.6

1.2

6.49

6.72

g/l

0.29

116

177

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

444

1361

3.05

95.53

1.9

2.1

38.08

41.06

u/l

2.40

393

1264

(3010421) pH of Blood

254

549

4.26

92.03

4.7

2.5

7.42

0.20

233

525

(3024928) Oxygen saturation in Venous blood

196

345

5.21

90.78

3.5

3.9

—

(4146454) Self-monitoring of blood glucose

12.84

89.54

2.9

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

206

384

4.92

89.42

1.2

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

317

824

3.56

88.84

1.7

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1633

8958

1.81

87.48

3.8

2.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

267

623

3.95

87.35

1.8

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

167

264

5.78

86.73

1.4

1.2

0.65

3.05

u/ml

1.94

146

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

408

1260

3.01

86.53

2.1

1.8

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

113

115

8.93

86.45

1.9

1.7

0.87

0.70

nmol/l

1.52

105

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1736

9736

1.78

86.17

1.7

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

213

429

4.55

84.32

1.6

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

266

638

3.84

83.75

1.8

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

313

841

3.44

83.38

1.8

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2581

16296

1.64

81.93

4.1

2.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

786

3421

2.19

81.49

2.7

2.2

37.41

45.75

u/l

0.62

661

2976

(3015171) Extractable nuclear Ab [Units/volume] in Serum

386

1195

3.00

81.46

1.2

3.71

0.53

u/ml

1.01

100

(3006184) Hemoglobin [Mass/volume] in Capillary blood

239

546

4.02

80.46

2.4

1.8

132.68

132.72

g/l

0.01

160

367

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

177

320

5.06

79.56

1.3

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

959

4545

2.02

79.35

7.6

3.7

—

(3012501) Base excess in Blood by calculation

219

475

4.23

78.97

5.1

2.6

3.03

2.48

mmol/l

1.82

160

310

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

248

594

3.84

78.22

1.3

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

366

1135

2.99

76.96

2.0

1.7

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

257

646

3.66

75.64

1.6

1.4

0.60

2.85

iu/ml

0.43

142

(3023183) Ammonium ion [Moles/volume] in Plasma

180

346

4.76

75.38

2.9

2.5

34.17

35.68

umol/l

0.28

164

319

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

160

280

5.22

74.59

1.7

1.3

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

218

496

4.03

73.78

3.0

2.8

3.80

3.79

e9/l

0.02

218

496

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

179

350

4.68

73.45

1.6

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1055

5300

1.91

73.36

4.6

3.5

32.98

31.96

2.18

765

3440

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

299

847

3.26

73.21

1.2

17.57

20.20

u/ml

0.07

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

216

491

4.03

73.20

2.9

2.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

380

1245

2.83

72.32

1.4

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

129

189

6.21

72.28

2.6

2.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

909

4384

1.98

71.13

1.8

1.3

1.47

1.21

19.83

783

4001

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

223

530

3.86

71.09

3.2

3.0

56.48

55.70

0.40

223

530

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

313

931

3.10

70.68

6.3

3.8

1.66

1.59

0.61

280

863

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

226

548

3.78

70.04

1.2

1.1

20.29

6.43

u/ml

0.46

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

152

271

5.11

69.41

6.2

5.4

11.07

11.34

mg/l

0.26

139

257

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

272

751

3.33

69.38

1.2

8.69

4.58

u/ml

0.27

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

103

8.37

69.24

1.2

1.1

50.58

12.38

iu/ml

0.66

(3025941) Bacteria identified in Stool by Culture

531

2094

2.37

69.19

1.3

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

268

737

3.35

68.79

1.2

2.66

2.13

u/ml

0.21

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

239

610

3.60

68.76

3.5

4.2

59.96

46.22

mg/l

0.21

183

526

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

198

445

4.07

68.13

1.7

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

163

314

4.74

68.09

1.7

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

238

611

3.58

67.88

3.5

4.2

46.81

121.64

mg/l

0.47

182

522

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

234

594

3.62

67.87

3.5

4.2

2.90

5.68

ratio

0.34

(3017732) Neutrophils [#/volume] in Blood

650

2819

2.17

67.50

2.9

2.0

5.82

4.26

e9/l

1.13

522

2450

(3036489) Thrombin time

362

1204

2.78

66.93

2.2

1.9

21.84

20.90

1.58

319

1025

(3010838) Calcium [Moles/time] in 24 hour Urine

235

605

3.56

66.74

2.1

1.9

5.94

5.76

mmol/24h

0.14

198

548

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

165

328

4.59

66.38

1.6

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

315

976

2.98

66.26

2.6

2.3

3.74

3.54

g/l

1.26

305

924

(3007930) Methemoglobin/Hemoglobin.total in Blood

303

920

3.04

66.03

6.4

3.8

0.92

0.94

0.40

271

851

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

282

821

3.16

65.99

2.1

2.2

11.24

10.07

mg/l

1.75

260

782

(3019230) Fractional oxyhemoglobin in Venous blood

161

316

4.65

65.77

3.4

3.8

64.92

61.02

1.12

161

316

(3019150) Specific gravity of Urine by Refractometry

1462

8355

1.71

65.51

4.1

2.6

1.02

kg/l

0.39

196

1316

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

303

931

3.00

64.67

2.5

2.4

7.31

7.03

g/l

1.66

265

869

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

302

929

3.00

64.33

2.5

2.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

274

797

3.16

64.21

2.6

1.13

0.98

g/l

0.14

231

711

(3047181) Lactate [Moles/volume] in Blood

278

817

3.13

64.03

6.9

3.9

1.26

1.16

mmol/l

1.11

236

717

(3002385) Erythrocyte distribution width [Ratio]

5685

44468

1.61

63.81

21.9

9.4

15.28

14.47

18.25

5592

43460

(3004616) Nuclear Ab [Presence] in Serum

162

328

4.51

63.73

1.4

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

884

4377

1.92

63.63

1.6

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

300

929

2.98

63.16

2.5

2.4

3.74

3.69

g/l

0.19

264

867

(40761535) Cells panel - Urine sediment

595

2561

2.18

62.83

3.5

2.4

—

(40761536) Microorganisms panel - Urine sediment

688

3132

2.07

62.82

4.7

2.7

—

(3003181) Sodium [Moles/volume] in Urine

155

308

4.59

62.39

1.4

1.3

63.42

68.83

mmol/l

0.65

126

249

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

292

899

2.99

62.10

2.5

2.88

2.81

g/l

0.63

256

837

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6415

51883

1.76

61.80

5.2

3.5

2.74

3.09

mmol/l

171.54

5891

48219

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

221

586

3.46

60.03

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

221

586

3.46

60.03

1.3

1.2

—

(3037756) Immunofixation for Serum or Plasma

179

412

3.97

59.65

1.6

2.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

678

3132

2.04

59.37

2.5

2.3

19.74

22.83

au/ml

0.27

366

(3052851) Hemolysis interference index of Serum or Plasma

287

898

2.94

59.31

3.3

2.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6076

48582

1.64

59.08

4.2

3.0

1.29

1.18

mmol/l

26.30

5530

45058

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

631

2847

2.08

58.88

1.4

1.3

43.46

54.20

au/ml

0.57

192

(36660697) Celiac disease serology panel - Serum

696

3265

2.01

58.36

1.2

1.1

—

(3007461) Platelets [#/volume] in Blood

7138

60040

2.40

58.08

28.0

11.1

256.09

255.10

e9/l

0.64

7007

57921

(3009542) Hematocrit [Volume Fraction] of Blood

7129

59958

2.37

57.51

28.4

11.1

40.07

41.00

5.83

6774

56353

(3035941) MCH [Entitic mass]

7139

60118

2.38

56.64

27.9

11.1

30.26

30.25

0.38

7056

59063

(3010813) Leukocytes [#/volume] in Blood

7140

60140

2.38

56.42

28.0

11.1

6.80

6.31

e9/l

60.02

6999

57828

(3024731) MCV [Entitic volume]

7139

60130

2.38

56.38

27.9

11.1

91.03

90.56

15.70

7057

59068

(3026361) Erythrocytes [#/volume] in Blood

7139

60139

2.37

56.18

28.0

11.1

4.46

4.55

e12/l

45.67

6998

57847

(3003327) Ova and parasites identified in Stool by Light microscopy

366

1338

2.53

56.02

1.8

1.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

182

444

3.74

55.93

3.4

4.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

248

741

3.07

55.53

2.5

2.4

38.04

39.33

g/l

2.41

209

678

(3000963) Hemoglobin [Mass/volume] in Blood

7139

60171

2.36

55.49

28.2

11.1

134.09

137.04

g/l

58.51

7056

59124

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4666

35457

1.48

54.56

3.5

3.0

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

275

880

2.87

54.56

2.5

10.05

10.12

g/l

0.07

239

816

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

187

473

3.61

54.53

1.7

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

187

473

3.61

54.53

1.7

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6302

51135

1.66

54.27

4.7

3.3

4.64

5.06

mmol/l

184.56

5811

47838

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6269

50803

1.65

54.20

4.7

3.3

1.47

1.57

mmol/l

68.73

5749

47439

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1785

11171

1.57

54.16

1.7

1.5

1.40

1.25

mmol/l

9.20

1492

9697

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

194

510

3.48

53.40

5.4

4.5

482.65

516.31

iu/ml

0.05

(46235355) HIV 1 and 2 tests - Meaningful Use set

1403

8316

1.63

53.35

1.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

220

627

3.21

53.31

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

103

7.12

51.75

1.4

1.0

1.47

1.01

promille

1.44

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

142

307

4.21

51.46

1.6

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

142

307

4.21

51.46

1.6

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

237

724

3.00

51.08

2.7

2.5

0.03

0.02

g/l

0.24

214

686

(3041096) Erythrocytes [Presence] in Urine by Automated

1850

11803

1.54

50.99

3.6

2.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

187

498

3.43

50.47

1.6

2.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

7.20

50.36

5.0

3.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

312

1117

2.57

49.83

2.6

2.0

92.73

94.30

0.53

298

1056

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

11.96

49.56

1.6

1.4

108.77

182.05

umol/l

0.31

(3008295) Osmolality of Serum or Plasma

108

192

5.10

49.53

1.6

1.5

280.13

278.28

mosm/kgh2o

0.36

164

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

303

1073

2.60

49.48

2.2

2.0

5.30

4.24

iu/l

0.89

126

454

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

149

345

3.93

49.29

1.4

1.2

—

nmol/l

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

185

497

3.40

49.27

1.7

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

292

1023

2.62

48.72

1.1

—

(3039000) Anion gap in Blood

199

564

3.22

48.67

8.2

4.7

11.05

10.79

mmol/l

0.52

171

498

(3018572) Chloride [Moles/volume] in Blood

199

565

3.22

48.53

8.2

4.7

105.30

105.58

mmol/l

0.39

171

499

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

288

1007

2.63

48.24

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

627

3026

1.94

48.13

3.1

2.1

66.70

75.22

ml/min/173m2

6.25

288

995

(42529406) Shigella sp [Presence] in Stool by Culture

292

1030

2.61

48.06

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

12.11

48.05

1.6

1.3

0.39

0.51

ug/l

0.69

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

161

405

3.62

47.36

1.4

1.2

0.27

0.19

nmol/l

0.22

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

161

406

3.61

47.19

1.4

1.3

0.61

0.59

nmol/l

0.23

154

395

(3038026) Centromere Ab [Units/volume] in Serum

101

179

5.12

46.50

1.2

46.60

52.14

u/ml

—

(3049717) Cytology report of Urine Cyto stain

315

1171

2.48

46.49

2.5

2.7

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

218

675

2.95

45.89

2.7

2.5

0.01

0.00

g/l

0.70

195

638

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

131

294

4.05

45.22

1.9

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

659

3298

1.87

45.20

1.3

1.2

118.38

162.41

iu/ml

2.37

245

1383

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

214

673

2.91

43.83

2.7

2.5

0.00

g/l

-0.00

195

638

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

425

1843

2.13

43.72

2.4

2.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

282

1025

2.53

43.64

2.6

2.1

184.53

173.99

1.20

273

962

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

180

4.94

43.35

1.2

34.50

11.00

u/ml

—

(3007566) Smooth muscle Ab [Titer] in Serum

234

779

2.75

43.14

1.2

1.3

104.07

252.50

titre

1.14

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

183

4.85

42.54

1.8

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

145

368

3.58

42.13

1.4

1.3

—

(4035726) Immunohistochemistry procedure

835

4611

1.70

40.84

1.5

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

574

2843

1.88

40.53

1.3

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

247

874

2.59

40.40

3.4

4.0

1.44

1.14

mg/l

6.63

235

832

(3009466) Valproate [Moles/volume] in Serum or Plasma

105

217

4.39

40.36

5.4

3.4

345.08

371.06

umol/l

0.86

182

(3034770) Mitochondria Ab [Titer] in Serum

226

766

2.70

40.26

1.2

853.33

1042.50

titre

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

208

681

2.79

39.58

1.4

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

128

312

3.73

39.46

1.5

1.6

—

(3004451) EKG impression Narrative

9.41

39.15

1.3

1.1

—

(3017569) Oxygen content in Arterial blood

7.88

38.40

2.1

2.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

141

5.20

38.08

1.6

1.1

5.79

5.88

u/l

0.04

116

(3051593) INR in Capillary blood by Coagulation assay

15.77

38.00

7.4

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

136

358

3.45

37.44

1.4

1.5

—

(3011412) CD3 cells [#/volume] in Blood

125

311

3.65

37.43

1.8

3.2

1.29

1.24

e9/l

0.29

108

289

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

117

278

3.82

37.41

1.6

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

138

367

3.42

37.40

1.4

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

135

356

3.45

37.07

1.4

1.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

100

216

4.20

36.37

1.8

3.7

0.26

e9/l

0.04

191

(3002256) Pathology report gross observation

1103

6733

1.55

35.58

1.3

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

132

353

3.40

35.48

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

151

440

3.12

35.35

1.4

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

132

354

3.39

35.33

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

300

1232

2.23

35.31

1.3

1.2

—

(3011985) Renin [Units/volume] in Plasma

136

373

3.31

35.14

1.6

64.76

74.09

mu/l

0.11

123

337

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

131

354

3.36

34.66

1.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

237

887

2.44

34.49

1.3

1.4

522.21

529.85

mg/l

0.06

227

840

(40757494) Bilirubin.total [Moles/volume] in Blood

6.47

34.10

1.7

1.8

13.40

125.67

umol/l

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

201

699

2.62

34.08

1.2

1.1

57.80

28.10

u/ml

1.46

(3045414) Leukocytes [Presence] in Urine

362

1626

2.05

33.87

1.8

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

572

2988

1.78

33.83

1.4

1.5

—

(3044927) Protein electrophoresis panel - Urine

169

4.50

33.43

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

124

332

3.39

33.29

1.5

1.4

33.48

38.93

g/l

4.25

113

317

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

223

3.98

33.29

1.9

2.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

227

3.95

33.29

1.8

3.6

530.80

568.89

e6/l

0.31

197

(3004809) Band form neutrophils/100 leukocytes in Blood

142

418

3.09

32.71

2.7

3.2

1.65

2.10

0.51

131

381

(3021788) Differential panel - Synovial fluid

154

480

2.92

32.12

1.5

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

342

1542

2.04

31.66

1.6

1.7

—

(3040151) Glucose [Moles/volume] in Capillary blood

208

4.00

31.55

4.9

2.6

6.73

5.94

mmol/l

1.68

169

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1082

6758

1.51

31.05

1.6

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

123

343

3.25

31.00

1.2

1.1

25.94

30.88

u/ml

—

(3020876) Protein [Mass/time] in 24 hour Urine

219

3.89

30.95

2.3

2.8

1.04

1.47

g/24h

0.49

103

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

169

4.34

30.84

2.0

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

110

287

3.47

30.76

3.3

3.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

130

4.87

30.66

2.0

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

194

699

2.53

30.63

1.3

1.2

—

(21494755) Public health laboratory ask at order entry panel

506

7492

0.58

30.63

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

136

406

3.04

30.61

1.9

1.8

26.32

27.26

mg/l

0.06

110

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

297

1288

2.11

30.50

1.2

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

177

618

2.61

29.81

1.5

1.4

12614.36

12237.19

e6/l

0.04

125

430

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1872

13035

1.38

29.72

5.1

4.8

2.69

3.63

ug/l

0.93

1662

11967

(3023199) Leukocytes [#/volume] in Pleural fluid

113

307

3.34

29.70

1.6

1.4

2522.29

3064.45

e6/l

0.34

220

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

120

4.97

29.62

2.0

1.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

332

1520

2.00

29.46

1.1

1.28

1.60

u/ml

—

(3011288) Drugs identified in Urine by Screen method

192

703

2.49

29.32

2.8

1.8

—

(3037121) Protein [Mass/volume] in Urine

263

1105

2.18

29.29

3.5

3.8

0.26

0.22

g/l

0.52

122

510

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

123

356

3.13

29.19

1.3

1.4

315.66

507.66

pmol/l

1.02

113

316

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

122

4.89

29.07

2.1

1.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

140

438

2.90

29.04

2.8

2.5

3757.71

2066.66

u/ml

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

261

1097

2.18

29.04

1.2

1.1

—

(3016038) Potassium [Moles/volume] in Urine

124

4.81

28.54

1.2

1.3

33.29

37.63

mmol/l

0.72

112

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

11.08

28.54

2.5

1.2

19.33

4.00

ug/min

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

208

3.83

28.43

2.6

2.1

—

(3019977) pH of Arterial blood

5.64

28.34

1.8

2.2

7.42

0.16

(3026389) Candida sp identified in Specimen by Organism specific culture

157

530

2.69

28.28

1.4

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

200

761

2.39

28.12

1.3

1.4

3.68

3.44

mmol/l

2.76

187

717

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

140

449

2.83

27.78

1.3

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

368

1781

1.90

27.77

2.9

2.1

0.33

0.24

e6/l

0.37

359

1718

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

114

325

3.18

27.76

1.6

1.4

54.80

52.88

0.17

191

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

5.51

27.69

3.4

2.3

38962.55

37726.94

ug/l

0.22

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

179

654

2.49

27.48

1.3

300.80

229.61

u/ml

1.74

105

418

(3045424) Erythrocytes [Presence] in Urine

165

583

2.57

27.16

1.6

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

198

762

2.37

27.15

1.5

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

779

4672

1.55

26.72

4.1

4.6

8.67

34.60

ug/l

2.47

643

3670

(3017704) Immunofixation for Urine

101

5.09

26.36

1.4

2.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

306

1416

1.98

26.36

1.4

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

102

283

3.26

25.98

1.5

1.4

112450.39

38252.67

e6/l

0.71

172

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

191

738

2.36

25.97

1.5

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

772

4667

1.54

25.49

1.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

456

2418

1.74

25.48

1.1

1.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

217

3.58

25.34

1.4

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

217

3.58

25.34

1.4

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

217

3.58

25.34

1.4

1.8

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

262

3.32

25.11

1.6

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

246

3.38

24.85

2.8

3.5

62.34

54.96

2.48

216

(3012441) Differential panel - Pleural fluid

274

3.24

24.67

1.6

1.4

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

118

4.59

24.62

1.3

1.2

116.88

111.64

0.55

107

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

195

779

2.28

24.58

1.5

876.19

1284.61

e6/l

0.37

157

645

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

195

779

2.28

24.58

1.5

61.32

26.55

e6/l

0.51

148

617

(3004775) Volume in Urine collected for unspecified duration

6.89

24.37

2.6

2.3

726.41

627.52

0.58

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

128

421

2.76

24.28

1.1

1.47

1.44

g/l

0.33

117

388

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

5.76

24.26

2.0

1.4

1080.33

425.71

u/ml

—

(3044242) Glucose [Moles/volume] in Arterial blood

5.76

24.26

2.0

2.3

—

(3000012) Reticulocyte production index

276

3.18

23.75

2.0

2.3

—

(3032057) Clostridioides difficile [Presence] in Stool

8.03

23.45

1.6

1.9

—

(3051611) Lipemic interference index of Serum or Plasma

109

335

2.95

23.42

3.2

2.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

179

3.74

23.21

1.1

15.86

15.18

nmol/l

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

175

688

2.31

22.92

1.5

1.3

145.92

108.38

u/ml

0.66

152

(3014271) Vancomycin [Susceptibility]

5.30

22.74

3.0

2.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

102

308

3.00

22.61

3.1

3.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

285

3.08

22.54

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

539

3086

1.61

22.45

2.2

1.9

11.62

13.24

nmol/l

4.41

455

2830

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

147

3.99

22.38

1.2

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

219

954

2.09

22.29

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

125

426

2.66

22.19

1.9

1.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

100

303

2.99

22.05

1.2

54.79

70.26

u/l

2.07

270

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

175

3.66

21.70

1.5

1.4

7.28

5.24

u/l

0.65

138

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

121

411

2.67

21.63

1.1

—

16.19

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

7.25

21.56

1.3

7.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

5.20

21.36

1.3

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

216

3.35

21.34

1.5

6.83

8.17

ug/l

0.44

196

(3020961) Endomysium IgA Ab [Titer] in Serum

398

2136

1.71

21.28

1.2

1.1

371.00

229.78

titre

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

161

3.76

21.24

1.1

88.32

70.79

u/l

0.43

148

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

153

3.84

21.21

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

5.13

21.07

2.2

2.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

130

4.10

21.04

1.3

1.2

0.32

0.29

g/l

1.58

102

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

112

372

2.73

20.92

1.1

1.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

270

3.05

20.83

1.7

1.1

59.14

—

iu/ml

—

(21494815) CD4 cells/100 lymphocytes in Specimen

102

324

2.85

20.70

2.1

2.5

40.59

35.88

2.06

324

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

160

3.72

20.67

1.1

31.53

16.98

u/l

0.35

147

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

236

1087

1.98

20.65

1.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

4.89

19.95

2.2

1.2

65.78

1898.97

mg/l

0.49

(1002224) Polysomnography panel

356

1889

1.72

19.84

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

140

3.87

19.84

1.2

165.68

158.47

mmol/24h

0.16

140

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

182

3.47

19.81

1.1

11.62

9.62

u/ml

0.15

(3011648) Oxygen content in Venous blood

161

3.64

19.76

2.8

4.9

11.60

11.62

0.01

161

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

254

1222

1.89

19.57

1.1

1.83

5.98

u/ml

2.20

233

(3016750) Collection duration of Urine

6.25

19.46

2.7

2.3

479.88

499.45

min

0.37

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

311

2.82

19.38

1.2

40.37

42.85

mg/l

0.21

252

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

790

5072

1.44

19.16

2.1

1.8

—

(3016018) Differential panel - Cerebral spinal fluid

112

391

2.59

19.01

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

219

3.18

18.95

1.3

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

5.06

18.92

1.6

1.2

56.21

60.16

0.21

(3051651) Icteric interference index of Serum or Plasma

179

3.43

18.90

3.6

3.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

184

800

2.09

18.88

1.2

1.1

13.93

10.02

au/ml

0.32

(21494890) Protein electrophoresis panel - 24 hour Urine

215

3.19

18.87

2.5

—

(40768806) Pleura Pathology biopsy report

316

2.78

18.83

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

102

4.33

18.83

1.1

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

4.72

18.76

1.5

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

249

3.01

18.68

1.3

2.08

1.90

mmol/l

0.51

235

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

221

3.15

18.67

1.3

1.1

—

(3012565) Volume of 24 hour Urine

126

3.94

18.66

1.7

2.4

2098.70

2122.82

0.05

120

(3010375) cycloSPORINE [Mass/volume] in Blood

4.99

18.64

22.7

32.0

112.21

123.72

ug/l

0.47

(44813793) Dust mix specific IgE antibody measurement

303

2.81

18.62

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

135

3.81

18.48

1.3

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

253

1239

1.86

18.47

1.3

1.4

13.09

11.16

u/l

1.04

203

1018

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

132

3.83

18.28

1.3

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

158

3.54

18.11

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

221

3.11

18.05

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

221

3.11

18.05

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

221

3.11

18.05

1.2

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

202

933

1.97

17.59

2.1

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

206

3.16

17.57

1.3

1.2

185.00

75.20

titre

0.63

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

4.31

17.24

2.4

2.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

116

433

2.43

17.17

1.3

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

247

2.93

17.16

1.1

—

(40768443) Skin Pathology biopsy report

349

1919

1.66

17.06

1.1

1.2

—

(3045788) Cell count panel - Pleural fluid

239

2.95

16.96

1.5

1.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

7.50

16.81

2.2

1.3

10.24

10.62

mg/l

0.10

(3008898) HLA-B27 [Presence]

293

1543

1.73

16.81

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

217

3.04

16.73

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

217

3.04

16.73

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

217

3.04

16.73

1.2

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

5.50

16.68

1.6

1.3

23.88

20.24

0.22

(3035880) pH of Pleural fluid

121

3.80

16.53

1.5

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

102

4.06

16.34

1.7

2.8

181.25

277.14

e6/l

0.74

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

192

3.15

16.34

1.5

1.2

12.77

13.94

u/l

0.34

187

(3042733) HLA Ab [Presence] in Serum

6.88

16.26

5.0

4.3

—

(37021550) Renin [Units/volume] in Plasma --upright

5.69

16.24

1.3

1.5

43.62

58.45

mu/l

0.27

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

306

2.66

16.17

1.1

274.94

262.74

mg/l

0.22

269

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

4.17

15.78

1.6

1.5

14.25

14.10

pmol/l

0.08

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

269

2.75

15.78

1.3

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

857

5772

1.37

15.65

2.2

1.9

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

202

3.04

15.63

1.0

1.1

0.98

1.03

u/l

0.46

102

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

110

419

2.38

15.61

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1468

10698

1.29

15.46

4.4

4.0

21.19

21.01

0.17

676

5204

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

163

734

2.01

15.30

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

230

2.87

15.15

1.1

1.0

278.00

288.91

mg/l

0.78

212

(3023410) Appearance of Cerebral spinal fluid

102

383

2.41

14.96

1.7

—

(3022621) pH of Urine by Test strip

429

2560

1.53

14.90

2.8

2.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

133

561

2.15

14.85

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

5.73

14.76

1.4

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

13.00

14.76

14.3

11.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

4.23

14.63

1.5

1.4

75.90

251.70

nmol/24h

0.78

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

221

2.86

14.49

2.3

2.8

40.50

38.74

0.31

105

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

531

6667

0.69

14.42

1.7

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

6.54

14.36

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

13.23

14.32

2.4

1.9

10.03

8.01

mg/l

0.30

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

127

534

2.15

14.31

1.3

1.2

1.75

2.84

u/ml

1.17

165

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.88

14.25

1.2

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

120

495

2.19

14.18

1.3

1.2

4.80

4.09

u/ml

0.16

205

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

224

2.82

14.15

1.7

1.4

40.95

40.50

0.03

124

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

106

3.74

14.01

1.4

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

106

3.74

14.01

1.4

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

115

3.60

13.90

1.7

2.75

2.27

nmol/l

0.22

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

193

2.94

13.78

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

216

1107

1.77

13.68

1.2

1.1

1.57

2.09

u/ml

0.29

121

536

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

5.70

13.67

1.2

1.1

—

(3036180) Methadone [Presence] in Urine

5.70

13.67

1.3

6.6

—

(3016244) Insulin [Units/volume] in Serum or Plasma

175

3.04

13.65

2.8

2.6

22.94

16.62

mu/l

0.78

165

(3038071) Oxygen [Partial pressure] in Mixed venous blood

13.79

13.45

15.7

11.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

236

2.71

13.39

1.6

1.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

154

720

1.94

13.05

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

161

768

1.90

12.86

1.5

1.3

27.62

32.35

u/l

0.94

129

641

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.82

12.81

3.3

1.5

—

(3042517) Benzodiazepines panel - Urine

30.56

12.78

1.5

2.6

—

(3016879) Cocaine [Presence] in Urine

237

1274

1.69

12.70

2.0

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

404

2464

1.50

12.68

1.3

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

185

927

1.81

12.67

2.7

1.9

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

124

545

2.06

12.51

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

102

3.62

12.50

3.0

27.43

27.11

umol/l

0.06

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

9.78

12.50

1.4

1.0

—

(3028433) Virus identified in Specimen by Culture

3.80

12.42

1.2

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

226

2.67

12.32

1.4

1.2

130843.32

83515.06

e6/l

0.15

153

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

152

722

1.91

12.32

1.8

1.7

188.98

209.68

pmol/l

1.56

140

689

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

102

418

2.21

12.31

2.3

2.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

154

738

1.89

12.16

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

213

2.71

12.08

1.0

1.1

—

(3044941) Cell count panel - Synovial fluid

102

426

2.16

11.77

1.5

1.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

4.76

11.73

1.1

1.2

0.83

0.68

umol/24h

0.64

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

163

808

1.83

11.60

3.5

3.8

70.38

520.28

u/ml

2.20

140

741

(42529582) MDA5 Ab [Presence] in Serum by Line blot

4.87

11.59

1.2

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

4.87

11.59

1.2

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

4.87

11.59

1.2

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

4.87

11.59

1.2

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

218

2.65

11.57

1.0

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

106

453

2.11

11.55

1.2

1.4

50.26

36.35

u/l

0.31

383

(3010726) Horse dander IgE Ab [Units/volume] in Serum

183

942

1.76

11.49

1.2

1.1

1.70

1.50

u/ml

0.10

428

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

240

2.56

11.46

1.2

—

titre

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

121

546

2.00

11.41

1.2

1.1

118.32

117.63

0.08

111

482

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

391

2.19

11.38

1.2

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

200

2.70

11.32

1.3

1.5

20.00

21.72

u/ml

—

(3036670) Protein [Mass/volume] in Synovial fluid

3.68

11.28

1.3

1.2

41.54

39.02

g/l

0.44

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

4.58

11.22

1.3

287.19

398.81

pmol/l

0.55

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.89

11.19

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

233

2.55

11.13

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

260

2.46

11.10

2.0

1.8

4.61

3.38

mg/l

0.77

252

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

127

589

1.95

11.09

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

5.72

11.09

3.6

1.1

7.13

5.96

mmol/l

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.72

11.09

1.8

3.3

15.20

18.29

umol/l

0.44

(3014133) Dog dander IgE Ab [Units/volume] in Serum

161

808

1.80

11.03

1.2

1.0

7.14

3.92

u/ml

0.37

347

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

163

2.87

11.00

1.9

1.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

307

2.32

10.86

2.1

2.9

18.09

19.32

nmol/l

0.47

300

(3022689) Creatine [Moles/volume] in Urine

5.04

10.66

1.3

1.1

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

8.99

10.62

1.6

2.05

4.24

mg/l

0.60

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

8.99

10.62

1.6

1.40

2.64

mg/l

0.47

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

8.99

10.62

1.6

1.10

2.32

mg/l

0.57

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

8.99

10.62

1.6

1.20

1.00

mg/l

0.17

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

8.99

10.62

1.6

2.71

1.36

mg/l

0.62

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

8.99

10.62

1.6

1.46

1.16

mg/l

0.24

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

8.99

10.62

1.6

3.82

3.51

mg/l

0.04

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

205

1118

1.66

10.48

1.7

1.6

43.65

44.16

nmol/l

0.08

198

1091

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

235

2.49

10.46

1.3

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

4.92

10.39

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.82

10.26

1.4

1.2

490.64

202.31

ug/l

0.32

(3021387) Prolactin [Units/volume] in Serum or Plasma

268

1570

1.55

10.20

1.7

1.6

347.18

271.46

mu/l

1.93

242

1425

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

322

2.24

10.16

1.1

10.32

9.68

iu/ml

0.09

(3003888) Timothy IgE Ab [Units/volume] in Serum

184

984

1.69

10.14

1.2

1.1

5.43

5.29

u/ml

0.03

507

(3003694) ABO and Rh group [Type] in Blood

1866

14527

1.20

10.13

1.5

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

4.33

10.12

1.7

1.4

99.18

78.00

ng/l

0.38

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

393

2.11

10.09

1.1

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

356

4510

0.69

10.07

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.25

9.90

1.1

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

153

2.83

9.89

1.2

1.1

155.94

381.38

ng/l

0.78

(3023430) Cat dander IgE Ab [Units/volume] in Serum

151

770

1.77

9.85

1.2

1.0

3.68

3.67

u/ml

0.00

287

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

263

1550

1.54

9.76

3.4

4.0

386.19

1755.16

u/ml

2.58

216

1330

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

133

655

1.84

9.73

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.84

9.66

1.2

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

113

3.11

9.49

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

176

948

1.68

9.47

1.1

0.55

1.09

u/ml

1.10

400

(3008037) Lactate [Moles/volume] in Venous blood

103

471

1.98

9.43

3.3

1.9

1.40

1.34

mmol/l

0.32

460

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

249

2.35

9.29

1.5

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

407

2.04

9.24

1.4

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

170

2.65

9.16

3.3

1.5

26.40

14.15

mg/l

0.48

105

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

121

2.98

9.06

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

116

561

1.87

9.02

1.6

1.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.50

8.97

1.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

10.19

8.88

12.0

4.0

5.01

6.16

mmol/l

0.60

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.50

8.82

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

128

2.88

8.80

1.6

1.4

3.22

2.52

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

121

598

1.83

8.80

1.6

1.4

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

356

2.08

8.69

2.5

2.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

3.83

8.68

1.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

140

2.77

8.57

1.1

1.0

7.96

15.23

u/ml

1.44

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

182

2.52

8.51

1.8

1.6

3.17

4.31

u/field

0.29

122

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

102

3.09

8.46

1.9

4.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

16.68

8.39

6.4

14.3

—

(3000764) Benzodiazepines [Presence] in Urine

243

1457

1.51

8.39

2.0

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

122

2.88

8.36

1.1

91.63

93.60

0.16

(3024932) HLA-DR beta [Type]

3.62

8.35

1.1

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

436

1.95

8.32

1.1

—

(3027008) Opiates [Presence] in Urine

245

1477

1.50

8.25

2.0

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.50

8.23

1.1

—

(3028300) Cannabinoids [Presence] in Urine

245

1478

1.50

8.22

2.0

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.49

8.17

1.6

1.2

—

(40757373) Influenza virus identified in Isolate

4.49

8.17

1.5

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

12.58

8.12

2.4

1.4

49.21

44.90

umol/l

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

8.49

8.10

1.8

1.0

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

176

2.51

8.09

1.4

1.3

3.99

4.65

umol/l

0.60

167

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

167

2.53

7.94

1.7

2.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

120

613

1.77

7.87

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

168

2.52

7.84

1.7

2.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

108

536

1.82

7.80

1.1

—

(3024471) HLA-A [Type]

3.42

7.69

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.00

7.63

1.2

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

119

2.80

7.58

1.1

90.24

95.88

0.35

(3006270) Folate [Moles/volume] in Blood

279

2.13

7.54

1.1

402.93

386.93

nmol/l

0.25

257

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.22

7.54

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

140

2.64

7.51

1.3

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

140

2.64

7.51

1.3

1.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

120

2.77

7.47

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

178

2.43

7.44

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.33

7.39

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.69

7.33

1.1

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.93

7.28

1.7

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.93

7.28

1.7

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

283

1800

1.43

7.28

2.2

2.1

5103.28

5598.73

u/l

0.09

784

(40768446) Kidney Pathology biopsy report

3.14

7.26

1.6

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

110

2.78

6.92

1.5

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.07

6.89

1.6

1.8

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

261

2.11

6.80

1.2

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

267

2.09

6.80

1.8

1.6

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

148

2.49

6.75

1.1

1.43

7.00

u/ml

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

4.36

6.73

1.2

0.56

2.11

mmol/l

0.56

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

117

2.69

6.71

1.2

—

(3027944) Amphetamines [Presence] in Urine

235

1470

1.45

6.65

1.8

1.4

—

(3034426) Prothrombin time (PT)

113

2.71

6.60

1.2

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

7.09

6.53

1.3

1.4

—

(3020491) Glucose [Moles/volume] in Blood

230

2.15

6.51

2.0

1.3

6.93

5.63

mmol/l

1.74

173

(3047189) Immunofixation for 24 hour Urine

119

2.65

6.51

2.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

272

2.05

6.50

1.2

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1057

8104

1.20

6.50

3.0

2.9

0.67

0.77

ug/l

4.00

680

5085

(3011436) Histone Ab [Units/volume] in Serum

3.88

6.49

1.0

1.1

—

u/ml

—

(3023511) Choriogonadotropin [Units/volume] in Urine

150

858

1.58

6.49

1.4

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

450

1.80

6.43

3.5

2.0

7.07

6.33

mmol/l

1.87

444

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

6.74

6.33

6.9

8.5

66.00

69.79

—

(3014891) Appearance of Pleural fluid

5.66

6.31

1.8

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

801

5998

1.22

6.29

1.5

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

143

2.45

6.25

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

123

677

1.64

6.24

1.1

1.0

0.20

0.29

u/ml

0.26

156

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.04

6.19

1.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

206

2.19

6.16

1.1

1.07

1.05

ratio

0.39

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

3.35

6.13

1.0

0.01

u/ml

0.03

(3014148) Varicella zoster virus Ab [Titer] in Serum

517

1.73

6.12

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

7.78

6.05

1.0

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

140

2.44

6.04

1.8

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

140

2.44

6.04

1.8

2.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

5.27

5.99

6.9

2.5

51.57

43.03

pmol/l

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.04

5.97

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

109

2.64

5.95

1.0

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

141

2.42

5.95

1.8

2.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

296

1.95

5.84

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

266

2.00

5.79

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

111

2.59

5.76

1.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

8.98

5.60

1.0

8.00

26.73

u/l

0.57

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.77

5.54

1.2

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.33

5.53

1.4

3.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

3.73

5.52

1.3

1.4

92.83

83.03

ng/l

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

253

1.99

5.48

1.3

1.2

79.88

76.77

umol/l

0.34

253

(4034850) Laboratory test

206

1307

1.43

5.47

12.3

4.7

—

(3013293) Extractable nuclear Ab [Presence] in Serum

8.23

5.36

1.3

1.9

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.15

5.33

1.2

114.25

162.15

nmol/l

0.77

(3029075) Extractable nuclear Ab panel - Serum

2.65

5.28

1.1

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.44

5.24

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

101

2.58

5.20

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

5.47

5.18

1.1

—

(40768441) Liver Pathology biopsy report

280

1.90

5.04

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

4.49

5.00

3.1

3.8

—

9.82

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

+∞

4.99

1.6

0.0

23.30

—

mg/l

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

+∞

4.99

1.6

0.0

—

(3000330) Specific gravity of Urine by Test strip

258

1730

1.35

4.96

3.4

2.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

10.10

4.93

30.3

8.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

126

2.36

4.91

1.1

2.84

26.77

u/ml

0.71

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

126

2.36

4.91

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

133

2.30

4.81

1.8

2.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

5.99

4.80

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

235

1.95

4.77

1.7

1.5

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

11.97

4.76

1.1

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.10

4.75

1.3

1.9

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

3.32

4.71

2.6

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.42

4.64

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

159

2.15

4.60

1.2

71.73

69.32

u/l

0.10

135

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.50

4.59

1.0

1.1

0.39

3.46

u/ml

0.62

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.55

4.58

1.1

1.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

109

2.39

4.49

1.1

1.3

3.40

17.60

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

155

2.15

4.47

1.2

15.19

15.24

u/l

0.00

127

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.21

4.47

1.2

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

655

4976

1.20

4.46

1.7

1.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.46

4.42

1.1

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

191

1246

1.38

4.41

1.9

1.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.49

4.37

1.1

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

240

2820

0.76

4.35

1.4

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

3.12

4.29

1.3

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

6.41

4.27

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

370

1.70

4.27

1.3

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

146

914

1.44

4.26

1.1

—

(3024263) Appearance of Synovial fluid

129

2.23

4.26

1.3

1.1

—

(3045142) Bone marrow Pathology biopsy report

439

1.64

4.24

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

101

2.40

4.24

1.9

—

(3003740) Influenza virus B Ag [Presence] in Specimen

146

915

1.44

4.24

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.58

4.19

1.0

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

154

2.10

4.15

2.1

2.3

43.86

51.64

umol/l

1.19

140

(40768795) Lymph node Pathology biopsy report

533

1.57

4.14

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

229

1.89

4.11

1.3

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

179

2.01

4.11

1.1

90.64

92.35

0.14

143

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

294

1.78

4.10

1.1

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

368

2661

1.25

4.08

1.9

1.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

385

1.66

3.97

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.93

3.96

1.2

1.1

—

(3036603) Volume of Urine

214

1.89

3.91

1.5

2441.27

1938.33

0.45

208

(3006462) Nitrate [Presence] in Urine

159

2.04

3.85

3.7

2.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.13

3.83

1.2

1.3

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

4.03

3.80

1.4

1.3

42.75

73.56

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

148

2.07

3.78

1.1

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.28

3.76

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

7.18

3.75

3.8

6.4

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

7.18

3.75

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

8.98

3.73

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

125

2.16

3.73

2.5

3.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

249

1737

1.30

3.72

1.3

270.33

228.66

miu/ml

0.84

107

936

(3028717) Thiamine [Mass/volume] in Blood

4.99

3.61

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

461

3461

1.21

3.61

2.0

1.7

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

2.32

3.54

1.0

1.2

2.48

20.30

u/ml

0.97

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

2.53

3.53

1.6

1.2

21.93

49.34

2.93

(3048879) Bone marrow aspiration report

2.45

3.48

1.7

2.7

—

(3020393) Adenovirus Ag [Presence] in Stool

3.07

3.47

1.3

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.85

3.41

1.1

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

271

1.73

3.41

3.4

2.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

241

1.75

3.27

2.0

1.7

2.17

2.31

u/field

0.05

101

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

157

1.95

3.27

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

3.43

3.27

1.9

1.3

5.88

14.86

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

8.98

3.26

1.2

1.0

—

(3001556) Androgen free Index in Serum or Plasma

3.95

3.25

1.1

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

235

1.76

3.24

3.0

1.7

—

(3030313) Adrenal Ab [Titer] in Serum

3.07

3.24

1.4

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

5.52

3.21

1.3

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1056

0.67

3.20

1.5

—

(3002619) Bacteria identified in Specimen by Culture

2.44

3.14

1.2

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.66

3.13

1.0

1.1

0.00

7.03

u/ml

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.08

3.08

2.3

2.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.24

3.08

1.2

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

620

1.44

3.00

2.1

2.4

4.70

6.18

umol/l

0.88

476

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

116

748

1.40

2.99

1.1

1.68

3.68

u/ml

3.26

458

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.41

2.93

1.2

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.25

2.92

1.0

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.53

2.92

5.9

6.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

132

874

1.36

2.91

1.2

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.27

2.90

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

3.27

2.90

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.42

2.80

1.0

—

(3036048) Francisella tularensis Ab [Titer] in Serum

116

2.01

2.78

1.0

1.2

—

1196.00

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

104

1283

0.72

2.75

1.4

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.29

2.73

2.1

1.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

101

1250

0.72

2.72

1.9

1.7

—

(3011897) Casein IgE Ab [Units/volume] in Serum

2.17

2.71

1.0

1.5

0.14

3.28

u/ml

1.58

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.85

2.69

1.6

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.84

2.65

2.5

3.5

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

5.98

2.64

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

4.22

2.64

4.1

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

224

1.69

2.61

2.0

1.9

2.12

3.75

ug/l

1.59

210

(3046861) Legionella sp Ag [Presence] in Urine

7.48

2.56

1.0

—

(3009015) Lactate [Moles/volume] in Synovial fluid

3.09

2.55

1.1

7.54

5.99

mmol/l

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

3.99

2.52

2.0

1.0

11.32

12.12

mg/l

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.99

2.52

3.3

7.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.10

2.51

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

103

1252

0.73

2.51

1.4

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.51

2.49

1.0

1.1

0.41

0.75

u/ml

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

4.49

2.48

1.1

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

129

876

1.33

2.47

1.3

1.4

0.31

0.42

nmol/l

1.28

683

(3005033) Fetal Nuchal fold Thickness US

103

1245

0.74

2.43

1.4

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

4.19

2.35

1.1

21.63

21.93

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

4.19

2.35

1.1

36.23

36.27

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

4.90

2.32

1.3

1.0

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

2.42

2.32

1.0

0.01

0.07

u/ml

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

198

1.68

2.31

1.4

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.82

2.31

1.1

1.60

1.45

umol/24h

0.21

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.59

2.30

1.0

—

(3025577) Chromium [Mass/volume] in Blood

219

1.64

2.29

2.0

1.49

2.90

ug/l

2.59

185

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.25

2.27

1.1

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

4.49

2.19

1.2

3.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

4.49

2.19

1.2

1.1

259.06

297.53

nmol/l

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

348

0.54

2.15

1.4

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.03

2.13

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.03

2.13

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.03

2.13

1.1

—

(3044007) Cell count panel - Peritoneal fluid

1.94

2.10

1.2

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

136

1.78

2.09

1.1

1.0

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.29

2.08

1.0

1.1

0.01

1.52

u/ml

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

4.14

2.06

1.2

1.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

380

2962

1.16

2.04

1.4

1.3

28.29

32.23

iu/l

1.50

333

2629

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

144

1.75

2.04

1.1

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

4.99

2.03

1.0

1.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.12

2.01

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

540

0.65

2.00

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

168

1854

0.81

2.00

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.39

1.97

1.3

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.39

1.97

1.0

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.79

1.95

1.0

—

(21494434) Karyotype in Bone marrow

295

1.49

1.93

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

1.91

1.93

1.3

1.4

13256.54

4899.88

e6/l

0.36

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.99

1.93

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

195

1.61

1.92

1.1

1444.31

1369.08

miu/ml

0.16

195

(3023487) Leukocytes [#/volume] in Peritoneal fluid

107

1.85

1.92

1.3

1.5

526.20

1508.94

e6/l

1.45

(3026480) Teichoate Ab [Titer] in Serum

3.31

1.92

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

3.31

1.92

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.47

1.92

3.2

1.6

0.55

0.90

u/field

0.57

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

228

2427

0.84

1.89

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1092

0.76

1.87

1.5

1.6

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.14

1.83

1.0

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

2.13

1.80

1.0

1.1

0.19

3.19

u/ml

—

(40765096) Chromosome analysis panel by Banding

110

1.80

1.78

1.0

1.2

—

(4212803) Bone marrow aspirate examination

2.76

1.77

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

4.08

1.76

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

4.08

1.76

1.0

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

179

1.61

1.75

1.7

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

122

1371

0.79

1.75

1.5

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

146

1608

0.81

1.75

1.4

1.5

—

(3008607) Semen analysis panel

2.99

1.74

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.52

1.73

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

3.37

1.73

1.2

1.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.37

1.73

2.3

1.3

—

(3003338) MCHC [Mass/volume]

5339

47006

1.07

1.73

23.8

9.6

332.00

333.05

g/l

14.99

5296

46590

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

699

0.72

1.72

1.1

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.93

1.71

2.0

1.4

7.43

8.63

ug/l

1.00

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.01

1.68

1.3

1.2

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

2.06

1.67

1.0

1.1

0.01

5.24

u/ml

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.20

1.66

1.0

1.1

—

(40762814) Titanium [Mass/volume] in Blood

2.12

1.66

2.4

2.3

4.30

4.21

ug/l

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.74

1.65

1.0

1.9

—

(1761868) Lipid panel - Serum or Plasma

2221

20784

0.94

1.63

2.7

2.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.03

1.61

3.4

2.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

191

1.55

1.59

1.2

1.3

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.45

1.55

1.2

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

400

0.65

1.53

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.92

1.51

1.4

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

245

1.47

1.51

1.0

857.33

687.89

ng/l

1.33

172

(3015183) Erythrocyte sedimentation rate

298

1.42

1.49

1.3

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

246

1.46

1.48

1.0

309.50

521.95

ng/l

0.80

183

(3033799) Differential panel - Peritoneal fluid

1.76

1.47

1.8

1.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

247

1.46

1.0

47.69

48.63

ng/l

0.04

179

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.51

1.44

2.7

2.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

129

948

1.22

1.44

4.6

2.4

24.70

27.25

mg/l

0.27

552

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.56

1.32

1.2

1.5

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.14

1.32

1.2

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

276

1.40

1.30

1.2

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.96

1.29

1.7

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

362

1.34

1.27

1.1

1.2

0.47

2.90

u/ml

2.05

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

142

1503

0.84

1.21

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

142

1503

0.84

1.21

1.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.64

1.20

1.2

1.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

954

0.81

1.19

3.9

2.1

13.10

13.13

0.13

940

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.34

1.19

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.34

1.19

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

142

1495

0.85

1.15

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

143

1497

0.85

1.09

1.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

114

1.58

1.09

1.3

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.36

1.07

1.0

1.6

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

110

0.49

1.05

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

2.09

1.04

1.1

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.91

1.02

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

231

1.36

0.96

1.9

2.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.83

0.92

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

172

1.41

0.91

1.2

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.76

0.91

1.4

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.07

0.89

1.0

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

143

1.44

0.89

2.8

2.9

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.89

0.88

2.4

4.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

403

0.76

0.87

1.2

1.3

1.59

1.60

g/l

0.04

403

(3021162) Amylase [Enzymatic activity/volume] in Specimen

1.68

0.86

3.4

2.6

6670.17

925.62

u/l

0.40

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

268

2188

1.10

0.83

2.0

1.4

3.42

3.40

mg/l

0.01

204

1395

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.75

0.83

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

318

1.27

0.81

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.71

0.80

2.0

4.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

116

902

1.16

0.80

1.7

—

(3009871) Measles virus Ab [Titer] in Serum

147

1.40

0.79

1.6

1.8

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.55

0.76

1.5

1.9

—

(4281824) Cell count and differential, peritoneal fluid

677

0.83

0.73

1.2

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

153

1.35

0.65

1.4

1.3

—

(3020650) Glucose [Presence] in Urine

124

1.38

0.61

1.9

1.3

—

(3019174) dRVVT (LA screen)

1.74

0.58

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.52

0.57

1.1

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

670

1.14

0.54

1.3

7.17

6.37

mmol/l

2.12

603

(3015076) Soybean IgE Ab [Units/volume] in Serum

353

1.20

0.54

1.1

0.19

3.78

u/ml

0.91

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

245

2045

1.08

0.53

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

112

1.36

0.53

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.54

0.53

1.0

8.54

8.41

mmol/l

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.43

0.46

3.7

8.3

35.29

62.25

g/mol

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

377

3216

1.05

0.45

2.5

3.8

33.42

44.66

u/ml

1.15

362

3130

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

262

1.20

0.44

5.9

6.1

43.50

12878.76

u/ml

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.42

0.40

3.7

2.8

—

(40765089) Chromosome analysis panel - Blood by G-banded

154

0.76

0.40

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

801

1.10

0.38

4.9

2.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1147

10533

0.97

0.38

1.5

1.4

—

(3017509) Phencyclidine [Presence] in Urine

1.45

0.36

1.3

1.1

—

(40768793) Breast Pathology biopsy report

170

1429

1.07

0.35

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

379

1.14

0.35

1.2

1.1

0.96

2.43

u/ml

1.25

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.38

0.34

1.7

1.1

—

(40768800) Prostate Pathology biopsy report

113

1095

0.92

0.34

1.1

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

168

1417

1.06

0.33

1.4

1.5

109.17

114.18

pmol/l

0.10

161

1388

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.37

0.31

1.1

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

273

1.15

0.31

1.8

1.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

408

3543

1.03

0.27

1.8

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

397

1.11

0.26

1.5

1.3

162.16

185.56

pmol/l

0.72

397

(3022475) Manganese [Moles/volume] in Blood

1.32

0.23

1.8

1.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.28

0.23

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.77

0.22

1.4

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.21

0.0

2.3

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.21

0.0

8.9

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

135

0.86

0.15

3.2

3.0

81.02

102.77

ng/l

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

231

2022

1.03

0.13

1.5

1.8

—

(3025130) Human papilloma virus identified in Specimen

105

911

1.03

0.11

1.7

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.04

0.08

1.2

1.5

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.82

0.08

1.2

1.1

—

(40758292) HTLV I+II Ab panel - Serum

1.05

0.07

1.1

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

748

1.01

0.00

1.4

3.82

3.79

ug/l

0.01

652

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

125

1.00

0.00

1.2

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.5

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.0

1.0

—

(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.6

—

78.00

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

0.00

-0.00

0.0

1.0

—

158.50

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.97

-0.00

18.3

4.5

—

Mortality – FinRegistry

↥

Association

Association between endpoint VOCALCORDDYS and mortality.

Females

Parameter	HR [95% CI]	p-value
VOCALCORDDYS	1.737 [1.58, 1.91]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.223

During the follow-up period (1.1.1998 — 31.12.2019), 3227 out of 21177 females with VOCALCORDDYS died.

Males

Parameter	HR [95% CI]	p-value
VOCALCORDDYS	1.823 [1.66, 2.0]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.013

During the follow-up period (1.1.1998 — 31.12.2019), 3762 out of 15769 males with VOCALCORDDYS died.

Mortality risk

Mortality risk for people of age

years, who have VOCALCORDDYS.

N-year risk	Females	Males
1	0.158%	0.418%
5	1.028%	2.325%
10	2.726%	5.509%
15	4.727%	10.609%
20	8.034%	17.177%

Relationships between endpoints

↥

Index endpoint: VOCALCORDDYS – Vocal cord dysfunction

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Vocal cord dysfunction

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints